The in vitro antiplasmodial properties of novel aminoquinolines and metal complexes of thiomethyl and methylthiomethyl ainline derivatives by Holland, Shamillah
THE IN VITRO ANTIPLASMODIAL PROPERTIES OF 
NOVEL AMINOQUINOLINES AND METAL 
COMPLEXES OF THIOMETHYL AND 




















I,"Shamillah"Holland,"declare" that" this"dissertation" is"my"own"work." It" is"






























          







“March on. Do not tarry. To go forward is to move toward perfection. 







To my Father,  
To my Mother, 
 
Thank you for your unrelenting support and constant source of 
love and encouragement through this journey, and through the 






To my uncle, Clifford Jousten, 
 
Thank you for giving me the gift of science and the passion for 



















































The" spread" of" drug" resistance" in" Africa" to" standard" antimalarials" has" equally"







dehydrogenase" assay" against" the" chloroquineVsensitive" 3D7" P.# falciparum" strain."
The" compounds" were" investigated" to" determine" a" possible" mechanism" of" action"
through"monitoring"the"inhibition"of"haemozoin"formation,"oxidative"stress"pathways,"
iron" and" copper" chelating" properties." The" toxicity"was" evaluated" by" examining" the"
effect"on"haemolysis"and"human"kidney"epithelium"and"erythroleukemia"cells."
The" aminoquinoline" derivatives" displayed" moderate" antimalarial" activity" in"
comparison" to"quinine" (IC50"value:"0.0964"±"0.002"μM)."This"was" theorized" to"have"
been"produced"through"a"proVoxidant"effect"that"had"no"effect"on"the"integrity"of"the"
red" blood" cell" membrane." Compounds" III+ and" V," both" aminoquinoline" derivatives"
displayed" antioxidant" activity" by" scavenging" of" free" radicals" and" inhibiting" lipid"
peroxidation,"possibly"by"their"gallic"acid"and"8Vhydroxyquinoline"components.""
The" copper" complexes" of" MA" and" MT" aniline" derivatives" displayed" promising"
antimalarial"activity"when"compared" to"quinine"with" its"activity"directed" towards" the"
parasite"and"not"the"host"red"blood"cells."CupMeO2MT"(IC50"value:"2.66"±"0.12"μM)"
and" Cu4MeO2MA" (IC50" value:" 2.82" ±" 0.38" μM)" were" the" most" active," and" were"





This" study" revealed" the" use" of" multiVcomponent" systems," as" well" as" the" use" of"
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(WHO,! 2015).! According! to! World! Health! Organization! statistics,! there! were!
approximately! 438! 000! malaria! deaths! worldwide,! 90%! of! which! occurred! in! the!
African!region.!In!2015!an!estimated!306!000!children!died!before!their!fifth!birthday!
due! to! malaria! globally,! the! majority! of! whom! reside! in! the! African! region! (WHO,!
2015).!Countries!of!Asia!have!also!been!affected!by!this!devastation,!to!some!extent!
as!a!result!of!its!poor!economic!status!in!parts!of!the!continent.!!Malaria!is!a!disease!
that! targets! the! vulnerable! population! groups!who! cannot! afford! treatment,! or!who!
have! limited! access! to! healthcare,! thus! keeping! families! in! poverty.! It! is! also! a!
disease! that! targets! the! immunocompromised! individuals! of! a! population,! in! Africa!
the!HIV!pandemic!has!been!superimposed!on! the! long!standing!malaria!pandemic!
which! has! brought! about! challenges! to! be! faced! with! regards! to! the! disease!
management!and!treatment.!!
!
Prevention! and! treatment! programmes! are! steered! by! information! obtained! by!
specified!surveillance!systems! that!are! implemented! in!all!areas!at! risk! for!malaria.!
The! information!obtained!from!these!surveillance!systems!may!be!used!to!assist! in!
distributing! resources! effectively! to! populations! most! in! need! of! assistance,! to!










falciparum* and! P.* vivax* predominate! in! areas! at! risk! for! malaria! with! P.* vivax*
estimated! to! be! responsible! for! 13.8!million!malaria! cases! globally! in! 2015! (WHO,!
2015)!
!
When! comparing! the! two! most! prevalent! types! of! malaria,! P.* falciparum!
predominates!in!Africa!and!causes!the!most!severe!infection!and!has!been!reported!
to! cause! the!majority! of! deaths! related! to!malaria! globally.!P.* vivax! infections! are!
more! common! in! areas! outside! of! Africa,! and! have! a! wider! distribution! than! P.*
falciparum.! P.* vivax! has! the! ability! to! progress! in! the! mosquito! at! much! lower!
temperatures!and!survive!in!!areas!with!cooler!climates!which!differs!when!compared!
to! P.* falciparum,! which! thrives! at! higher! temperatures,! which! would! explain! the!
difference!in!the!area!it!predominates.!With!each!species!there!are!variances!in!the!





Malaria! is! transfered! to! human! hosts! by! the! bite! of! an! infected!Anopheles! female!
mosquito!and!undergoes!an! intricate!sexual!developmental!cycle! in! the! insect!host!
(MolinaVCruz* et* al.,! 2012).! There! are! 400! different! species! of! the! Anopheles!




mosquito! species! differ! in! their! ability! to! effectively! transmit! malaria,! with! some!
species!being!highly!efficient! in!small!numbers!and!others!being!a!greater! threat! in!
larger!numbers.!The!Anopheles!species!responsible!for!infection!in!Africa!differ!from!
those! responsible! for! infection! outside! of! Africa! (WHO,! 2012).! The! behavior! and!
number! of! mosquito! vectors,! as! well! as! the! specific! reservoir! of! the! parasite!
determines! transmission! rates! of! malaria! for! a! specific! area! (Barnes,! 2012).! The!
diversity!in!the!parasite,!the!type!of!vector!predominant!as!well!as!taking!into!account!
each! contributing! factor! to! the! prevalence! and! spread! in! that! particular! area!




The! malaria! life! cycle! consists! of! two! different! developmental! stages,! namely! the!
asexual! intraVerythrocytic! (4)! and! sexual! gametocyte! stages! (5)! (Figure! 1.1).! The!
asexual! developmental! stage! of! the! parasite! occurs! within! red! blood! cells! of! the!
human! host! and! results! in! the! pathology! and! symptoms! of!malaria! (Baker,! 2010).!
The!sporozite!form!of!the!parasite!is!found!in!an!infected!mosquitoes’!salivary!gland!


























Individuals!at! risk! for!acquiring!malaria!are! those!who!are!nonVimmune!travellers! to!
malaria!areas.!Pregnant!women,!children!under!the!age!of!five,!as!well!as!the!elderly!
and!populations!who!are!immunocompromised!are!considered!especially!vulnerable!
to! infection! (SA! DOH,! 2010).! The! initial! symptoms! of! malaria! are! nonVspecific! in!
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uncomplicated!malaria!and!as!such!are!often!mistaken!for!a!systemic!viral!illness.!As!
a! result!malaria!may!be!overVdiagnosed!based!on! the!symptoms!alone! in!endemic!
areas,! which! leads! to! mistreatment,! or! it! is! undiagnosed! which! leads! to! a! more!







which! include!headache,! fatigue!as!well!as!abdominal!discomfort!and! later!develop!
into! fever,! chills,! perspiration! and! malaise.! At! this! early! stage! where! there! is! no!
evidence!of!vital!organ!dysfunction,!patients! that!are!readily! treated!progress! to! full!
recovery,! provided! the! treatment! is! prompt! and! the! correct! treatment! is! initiated.!
Although! in! certain! instances! where! these! treatment! protocols! are! not! followed!
patients! develop! severe! malaria! within! a! short! period! of! time.! Severe! malaria!
presents! as,! coma! or! cerebral!malaria,!metabolic! acidosis,! severe! anaemia,! acute!







or! oxidizing! agent,! and! inversely,! any! compound! able! to! donate! an! electron! is!
classified!as!a!reductant!or!reducing!agent.!Reduction!of!a!chemical!is!defined!as!the!
gain!of!electrons,!and!oxidation!is!in!turn!defined!as!the!loss!of!electrons.!In!order!to!
maintain! equilibrium,! oxidation! is! not! possible! without! reduction! elsewhere! in! a!
system! (Kohen! and! Nyska,! 2002).! ! Reductant! and! oxidant! are! used! in! chemical!








nucleic! acids,! and! may! result! in! the! development! of! specific! disease! states.! ProV
oxidants!may!be!classified!as!radicals!or!nonVradicals.!An!antiVoxidant!can!effectively!
reduce!a!proVoxidant!with!its!formed!products!to!a!level!of!having!little!to!no!toxicity!to!
prevent! biological! oxidative! damage! (Prior! and! Cao,! 1999).! The! tightly! regulated!
equilibrium!between!antiVoxidants!and!proVoxidants! is!known!as!redox!potential!and!
is! specific! to! each! organelle! and! biological! site! within! the! cell! as! well! as! the!
organism.!The!balance!of!this!equilibrium!within!the!cell!of!a!living!organism!can!alter!
changes!in!signal!transduction,!DNA!and!RNA!synthesis,!protein!synthesis,!enzyme!
activation!as!well!as! regulation!of! the!cell! cycle.!Life!sustaining!processes!such!as!
ligand!binding,!DNA!binding!and!nuclear!translocation!are!also!all!controlled!through!
redox!potential! (Schafer!and!Buettner,!2001).!Most! transcription! factors!needed! for!
protein!synthesis!are!found!only!in!the!reduced!state,!as!opposed!to!cell!death!that!is!
initiated! by! oxidizing! environments.! Therefore! the! redox! state! of! a! cell! would!






in! changes! in! cellular! function!due! to! the!movement!of!ROS!between!endogenous!
and! exogenous! sources.! Lipid! membranes,! DNA! as! well! as! enzymes! involved! in!
protein! synthesis! are! among! the! most! vulnerable! biological! targets! (Kohen! and!
Nyska,!2002)!(Figure:!1.2).!!
!
Cellular! membranes! are! particularly! prone! to! oxidative! damage! due! to! their! high!
levels! of! unsaturated! fatty! acids,! the! damage! caused! to! lipids,! described! as! lipid!
peroxidation!occurs!in!three!stages!and!results!in!a!loss!of!fatty!acids.!This!process!
involves! the! formation! of! a! fatty! acid! radical! as! a! result! of! the! loss! of! a! hydrogen!






















Proteins! serve! as! a! major! target! for! ROS! with! nitrogenVreactive! radicals! causing!
severe! damage! to! proteins.! Proteins! interact! directly! with! ROS! or! indirectly! with!
molecules!such!as!sugars!and! lipids,!generating!products! that!may! then! react!with!
the! protein.! Interactions!with!ROS! include,! peroxidation,! damage! to! specific! amino!
acid!residues,!changes!in!their!tertiary!structure,!degradation!and!fragmentation.!The!
result!of! this!protein!damage! includes!the! loss!of!enzymatic!activity,!altered!cellular!
functions! such!as!energy!production,! and!changes! in! the! type!and! level! of! cellular!
proteins.!Consequences!of!protein!oxidation!cause!changes!in!their!function!such!as!
chemical! fragmentation,! inactivation! and! increased! proteolytic! degradation! (Levine!
and! Stadtman,! 2001).! DNA! could! be! considered! the! most! biologically! significant!
target!with! regards! to!oxidative!damage,!and!continuous!oxidative!attack! results! in!
the!development! of! age! related! cancers! of! the!breast,! colon,! rectum!and!prostate.!






The! cell! is! under! steady! fluctuations! of! endogenous! and! exogenous! sources! of!
oxidative!stress!as!a!result!various!defense!mechanisms!have!been!put!into!place!for!
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protection! against! these! reactive! metabolites.! These! mechanisms! may! be! divided!
into!direct! as!well! as! indirect!methods! (Becker* et* al.,! 2004).! Indirect!methods!may!
involve! the! control! of! endogenous! production! of! ROS! for! example! by! altering! the!
activation! of! enzymes! that! produce! oxygen! metabolites.! Organisms! employ! an!
efficient!repair!system!consisting!of!small!molecules!as!well!as!enzymes!that!are!able!
to! efficiently! repair! oxidative! damage! on! macromolecules.! Physical! defense!







lowVmolecular! weight! antiVoxidants! (LMWA).! The! antiVoxidant! enzymes! are!
composed!of!direct!acting!proteins!such!as!super!oxide!dismutase,!amongst!others!
that! differ! in! their! structure! and! coVfactors! as! well! as! other! enzymes! that! act! by!
supporting! the! activity! of! the! antioxidants.! LMWA’s! employ! direct! and! indirect!
methods!in!counteracting!oxidative!stress.!One!of!the!most!significant!direct!methods!





Redox! reactions! and! processes! governed! by! redox! potential! are! essential! to! the!
survival! of! all! living! organisms.! This! tightly! regulated! balance! between! antioxidant!
and!proVoxidant!molecules!or!redox!state,!controls!life!sustaining!processes!such!as!
metabolism,!and!cellular!respiration.!A!considerable!decrease!in!the!redox!state!may!
lead!to!pathological!events!and! is!defined!as!redosis,!and!an! increase! in! the!redox!
state!would!in!turn!be!defined!as!oxidative!stress!and!may!lead!to!oxidative!damage!
to! biological! targets! (Shapiro,! 1972).! The! malaria! infected! RBC! is! under! constant!






Reactive! oxygen! species! (ROS)! are! proVoxidants! capable! of! causing! damage! to!
biological!targets!such!as!lipids,!DNA!and!protein.!These!ROS!are!generated!by!the!
malaria!parasite!as!a!result!of! its!high!metabolic! rate!due! to! its! rapid!multiplication.!
The!detoxification!of!these!ROS!pose!a!challenge!to!red!blood!cells!infected!with!the!
parasite,!and!results!in!oxidative!stress!within!the!infected!cell.!Host!haemoglobin!is!
the!most!abundant!source!of!amino!acids! for! the!malaria!parasite,!and! is! therefore!
needed! for! protein! synthesis! which! is! life! sustaining! to! the! parasite,! and! the!
degradation!of!host!haemoglobin! is!one!of! the!most! significant! causes!of!oxidative!
stress!within!the!parasite,!as!such!it!is!considered!an!endogenous!source!of!oxidative!
stress.!Within! the! red!blood!cells!of! the!host,! there!are!high!concentrations!of! iron,!
changes! in! the! levels! of! oxygen,! as!well! as!ROS! derived! from! the! host’s! immune!
response!and!is!considered!an!exogenous!source!of!oxidative!stress!for!the!parasite.!
There! are! various! other! factors! that! contribute! to! the! oxidative! stress! within! the!





Although! malaria! is! a! potentially! fatal! disease,! it! is! both! treatable! as! well! as!
preventable!given!the!correct!and!timeous!implementation!of!treatment!and!diagnosis!
coupled! with! the! correct! preventative!measures! employed.! Individuals! travelling! to!
malaria!areas!would!need! to!determine! the!need! for!chemoprophylaxis,!or!whether!
other!nonVdrug!preventative!measures!may!be!used! to!avoid!malaria! infection.!The!
decision!whether!to!use!chemoprophylaxis!or!nonVdrug!measures!is!a!complex!one,!
as! identifying! malaria! transmission! areas! are! difficult! due! to! the! fact! that! these!












and! as! such! campaigns! have! been! put! into! place! to! regulate! the! use! of! such!
products! in! order! to! decrease! the! increasing! insect! resistance.! The! use! of!
insecticide! treated! nets! as! well! as! long! lasting! insecticide! treated! nets! have!
effectively! decreased! transmission! levels,! however! recent! studies! have! shown!









for!prophylaxis! is!based!on! the! level!of! risk! for!malaria!as!well!as!being!part!of!
special! groups! identified! as! being! at! risk! for! malaria,! as! previously! discussed!
which! increases! the! need! for! prophylaxis.! Chemoprophylaxis! may! denote!
complete! prevention! of! infection! or! a! suppression! of! the! parasitaemia! and! its!
symptoms! or! clinical! prophylaxis.! Antimalarials! that! work! on! the! erythrocytic!
stages! of! the! parasite! and! terminate! the! asexual! stages! of! the! parasite! are!







asexual! stages!of! the!parasite! in!P.falciparum! and!has!also! shown!activity! against!
the!P.vivax!gametocytes!with!no!effect!on!the!hepatic!stages!of!the!parasite!(Rossiter!
and!Association,!2014).!Adverse!effects!associated!with!mefloquine! include!various!
central! nervous! system! effects! such! as! insomnia,! strange! dreams! and! mood!
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changes!which! usually! impact! on! the! decision! to! take!mefloquine! as!well! as! other!








the! preferred! shortVterm! prophylaxis! for! travellers! to! drug! resistant! malaria! areas.!
Doxycycline! acts! by! inhibiting! protein! synthesis! by! binding! to! the! 30S! ribosomal!
subunit! (Gaillard* et* al.,! 2016).! They! are! relatively! slow! acting! as! antimalarials! and!
may! be! used! not! only! for! prophylaxis! but! also! in! conjunction! with! conventional!
antimalarials! agents! to! increase! recovery! rates! (Staines! and! Krishna,! 2012).!
Doxycycline! prophylaxis! is! started! a! day! before! entering! the! malaria! area,! and!
continued!daily!while!in!the!malaria!area!as!well!as!daily!for!four!weeks!after!leaving!
the!area.!Doxycycline!has!an!adverse!effect!on!bone!formation!and!therefore!should!







AtovaquoneVproguanil! is! a! fixed! dose! combination! of! atovaquone,! an! inhibitor! of!
cytochrome! b,! and! proguanil,! a! dihydrofolate! reductase! inhibitor.! Both! of! these!




a! mild! adverse! effect! profile! with! nausea! being! the! most! common! symptom.! The!
combination! is! usually! taken! one! day! before! travelling! to! the! malaria! area! and!











if!a!mutant!parasite! is! resistant! to!one!of! the!drugs! in! the!combination,! the!second!





2015).! The!most! ideal! weapon! to! combat!malaria! would! be! the! development! of! a!
vaccine! that! would! prevent! infection! and/or! transmission! and! thus! eradicate! the!
disease.!The!use!of!a!vaccine!would!allow!for!longVterm!prophylaxis,!but!as!a!result!





ArtemisininVbased! combination! therapies! for! the! treatment! of! uncomplicated! P.*
falciparum! infection! are! comprised! of! artemisinin! and! its! derivatives,! artesunate,!
artemether!or!dihydroartemisinin.!There!are!minor!differences!in!oral!absorption!and!
bioavailability! between! the!different! artemisinin!derivatives,!which!do!not! show!any!
clinical! significance! to! the! combinations! used,! but! the! partner! compound! the!
artemisinin!is!combined!with!would!determine!the!overall!efficacy!of!the!combination.!
Artemisinin! produces! prompt! clearance! of! parasitaemia! and! fast! improvement! of!
symptoms! by! reducing! parasite! numbers! during! the! asexual! stage! of! the!
development! cycle.! Artemisinin! has! the! advantage! of! rapid! clinical! and!








being! more! tolerable! when! compared! to! the! alternative! treatment! option,! quinine!
(Blumberg,! 2015).! ArtemetherVlumefantrine! is! administered! over! a! period! of! three!
days,!and!the!number!of!tablets!to!be!administered!is!calculated!according!to!a!grade!
system! based! on! patient! weight.! Adverse! effects! are! generally! well! tolerated! and!
include! sleep! disturbances,! headache,! dizziness,! as! well! as! gastrointestinal!
disturbances.!Although!this!combination!is!well!tolerated!its!efficacy!in!severe!malaria!
has! not! been! established! and! should! only! be! used! in! instances! of! clear!






this! group! include! quinine,! chloroquine,! amodiaquine,! piperaquine,! primaquine! and!
mefloquine.! These! drugs! target! the! catabolism! of! the! hosts’! haemoglobin! by! the!
parasite!by!specifically!inhibiting!haemozoin!formation!by!the!parasite!(Egan,!2006).!
Oral! quinine! is! the! recommended! treatment! for! uncomplicated!malaria! in! pregnant!
women! and! infants! and! when! artemetherVlumefantrine! is! not! available! (Blumberg,!
2015).!Quinine!is!used!in!combination!with!either!clindamycin!in!the!case!of!an!infant!
or! pregnant! female,! or! in! combination!with! doxycycline! in! other! instances! for! both!




regimens! (Achan! et* al.,! 2011).! As! such! it! is! reserved! for! instances! where! an!
artemisinin! based! combination!may!not! be!used.!Minor! adverse!effects! associated!
with!quinine!use!are,!cinchonism,!which!includes!a!mild!hearing!impairment,!tinnitus,!
headache,! nausea! and! slight! visual! disturbances.! These! adverse! effects! are! dose!








The!WHO!defines! “drug! resistance”! as! the!ability! of! a! parasite! strain! to! survive! or!
multiply!despite!the!administration!and!absorption!of!a!drug!given!in!doses!equal!or!
higher! than! those! usually! recommended,! but! within! the! tolerance! of! the! subject!
(WHO,!1967).!The!pattern!of!malaria!disease!is!one!that!is!always!changing,!as!with!
all!components!of!medicine,!as!a!result!of!various!factors!related!to!malaria!evolving,!
the! development! of! resistance! has! been! documented! in! all! classes! of! antimalarial!
medication.!This!resistance!includes!the!class!of!artemisinin!derivatives!that!are!used!
globally! for!malaria! treatment! as! a! recommended! first! line! treatment! by! the!WHO,!
which! poses! a! significant! threat! to! the! possibility! of! malaria! elimination! (WHO!
Guidelines!for!malaria!treatment,!2015).!Drug!resistance!results!in!an!increase!in!the!
clearance! time!of! asexual! parasites! in! blood,!which! then!permits! the!production!of!
gametocytes!that!are!responsible!for!the!transmission!of!the!resistant!genotype.!Drug!
resistance!has!been!documented!not!only!on!the!basis!of!antimalarials,!but!has!also!
been! documented! specifically! in! three! of! the! five! malaria! species! known! to! effect!
humans,!namely,!P.*falciparum.**
*
P* .vivax! and! P.* malariae.! CrossVresistance! and! multiVdrug! resistance! have! both!
further! complicated! the! impact! of! resistance! that! has! emerged! with! antimalarial!
compounds.! CrossVresistance! may! occur! between! drugs! belonging! to! the! same!
class,!or!chemical!family!and!thus!have!similar!mechanisms!of!action.!An!example!of!
crossVresistance! documented! is! between! halofantrine! and! mefloquine.! Multi! drug!




resistance.!Treatment! failure! is! the! failure! to! clear!malarial! parasitaemia!or! resolve!
clinical! disease! following! treatment!with!an!antimalarial! drug.!Thus!drug! resistance!
may! result! in! treatment! failure,! but! not! all! treatment! failure! is! as! a! result! of! drug!
resistance.!Various! factors!contribute! to! treatment! failure!such!as,! incorrect!dosing,!
nonVcompliance!on!the!part!of! the!patient,!poor!drug!quality,!drug!interactions,!poor!
drug! absorption! as! well! as! incorrect! diagnosis! (Bloland! and! Organization,! 2001).!
Resistance!occurs! through!spontaneous!mutations! that! result! in! reduced!sensitivity!
to! a! given! drug,! or! a! particular! class! of! drugs! (Bloland! and! Organization,! 2001).!
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Factors! that! contribute! to! the! spread! of! resistance! are,! poor! treatment! practices,!
inadequate! patient! compliance,! the! widespread! availability! of! artemisinin!





The! high! incidence! of!malaria! documented! globally! as!well! as! the! development! of!
drug! resistant! strains! of! Plasmodium! has! highlighted! malaria! as! a! major! health!
concern,! as! such! new! avenues! need! to! be! explored! for! possible! treatment!
alternatives.!One!such!avenue!is!the!idea!of!metabolic!immunity!where!is!that!if!it!is!
possible! to! deprive! a! host! of! a! nutrient! essential! to! the! survival! of! an! invading!
organism! it! might! serve! as! a! host! defense! mechanism! and! essentially! provide! a!








such! as! DNA! synthesis,! carbohydrate! metabolism,! mitochondrial! function! and!
electron! transport,! amongst! others! (Mabeza! et* al.,! 1999).! The! intraerythrocytic!
parasite!multiplies!by!forming!16V32!daughter!cells!with!each!cycle!of!growth!and!this!
process! demands! a! high! concentration! of! the! hosts! ironf! which! are! accumulated!
during! the! trophozoite! stage! in! order! to! synthesise! the! required! DNA! during! the!
schizont! stage! of! the! parasite.! One! of! the! enzymes! critical! for! DNA! synthesis! is!
ribonucleotide! reductase,! which! is! an! iron! containing! enzyme! that! catalyzes! the!
reduction! of! ribonucleoside! diphosphates! to! deoxyribonucleoside! diphosphates,!
which! are! the! precursors! for! DNA! synthesis! (Munro! and! Silva,! 2012).! The!











Copper! is! an! essential! micronutrient! needed! as! a! cofactor! for! many! enzymes!
involved!in!metabolic!metabolism!required!for!survival!of!the!parasite!as!well!as!the!
human! host.! The! reductionVoxidation! property! of! copper! permits! it! to! receive! and!
donate! electrons,! which! renders! it! potentially! dangerous.! Organisms! thus! have!
specific!cellular!mechanisms!in!place!to!for!isolation!and!detoxification!to!ensure!that!
free! ionic! copper! is! kept! at! a! low! concentration! (Rasoloson* et* al.,! 2004).! Studies!
conducted!on!Plasmodium*infected!red!blood!cells!have!shown!a!decrease!in!copper!
content,!which!would!suggest!that!the!parasite! implements!an!efflux!mechanism!for!
its! metabolism! of! copper.! The! copper! required! by! the! parasite! for! growth! is! not!
imported! from!serum,!but! is!sourced!directly! from!the!host! red!blood!cell! (Goldring,!
2004).! Cuprozinc! superoxide! dismutase! is! the! most! prevalent! copperVcontaining!
enzyme!in!the!red!blood!cell,!and!is!believed!to!provide!a!possible!copper!source!for!
the! malaria! parasite.! During! the! ingestion! of! the! host! cell! cytoplasm! cuprozinc!
superoxide!dismutase!along!with!haemoglobin! is! taken!up!via! the!cytosome!and! is!
transported! into! the!parasites! food!vacuole!where!digestion!occurs,! the! fate!of! this!
digested! copper! is! not! known! (Rasoloson!et* al.,! 2004).!Although! this! is! so! studies!














A! chelating! agent! may! be! described! as! a! polydentate! ligand! that! is! capable! of!
occupying!two!or!more!sites!in!a!coVordination!sphere.!A!ligand!is!an!ion!or!molecule!
that!coVordinates!to!a!metal!atom!or!metal!ion!to!form!a!complex!(Brown!and!Lemay!
Jr,!2000).!Therefore!a!chelating!agent! is!a!metal!atom!or! ion! that!has! the!ability! to!
form!“bonds”!or!occupy!a!“space”!at!two!or!more!sites!within!a!coVordination!sphere,!
which! then! forms!a!stable!complex.!The! formation!of!complexes!between!chelating!
agents! and! metals! should! prevent! or! reverse! metal! binding! in! biological! ligands.!
Knowledge!of! the!structural!and!binding! features!of! relevant!metal! ions,!as!well!as!
the!mechanism!by!which!they!might!participate!in!biological!ligand!complexes!being!





The!proposed!antimalarial!action!of! iron!chelator’s! involve! their!penetration! into! the!
infected! parasite! erythrocyte,! binding! iron! within! the! parasite! cytosol! and! from! the!
labile!iron!pool!within!the!host!red!blood!cell!which!are!utilized!for!plasmodial!growth!
(Sekhon! and! Bimal,! 2012).! ! Studies! previously! conducted! on! the! growth! of! P.*
falciparum! in! cultured! red! blood! cells! in! the! presence! of! the! iron! chelating! agent!
desferrioxamine! have! demonstrated! that! iron! is! an! essential! nutrient! during! the!





Transferrin! is! the!most! important! iron!source! for! the!production!of!haeme!proteins,!
which! are! used! for! cellular! proliferation.! In! addition,! the! unique! means! by! which!
parasites!metabolise! iron!make! them!susceptible! to! a! drugVinduced! iron! deficiency!
scenario!(Mabeza!et*al.,!1999).!!The!mechanism!by!which!iron!chelators!exert!their!
antimalarial! effect! varies!and! they!may!either! isolate! iron!necessary! for! plasmodial!
replication,! or! it! may! be! through! the! direct! withholding! of! other! essential! trace!
elements!such!as!copper!and!calcium,!which!are!essential! to!parasite!metabolism.!
The! cytochromes! in! the! electron! transport! chain! of! almost! all! organisms! contain!
haeme,! inhibition! of! parasitic! haeme! synthesis! could! possibly! disrupt! electron!
transport! and! ultimately! result! in! the! arrest! of! mitochondrial! respiration! and! the!
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accumulation!of!ATP!and!eventually! result! in!death!of! the!parasite! (Mabeza!et*al.,!
1999).! Due! to! the! parasite’s! obvious! need! for! iron! to! complete! lifeVsustaining!
processes,! the! use! of! an! iron! chelator! would! cause! “iron! starvation”,! thereby!





action! for!neocuproine! is! that! it!would!enter!an! infected! red!blood!cell! via!diffusion!
and! then! chelate! copper! from! copperVcontaining! enzymes,! thereby! decreasing! the!
parasite! copper! supply! and! ultimately! decreasing! its! metabolism.! The! antimalarial!
activity!of!diethyldithiocarbamate!has!been!shown!as!a!result!of!its!potent!inhibition!of!








of! the!metal! complex!by!4.5! fold!when!compared! to! the!standard!drug! (Biot!et*al.,!
2012).!The! in*vitro*antimalarial!activities!of! the!copper! (II)!complexes!of!pyridineV2V
carboxamidrazones!have!clearly!shown! the!advantage!of!copper!complexation!and!
the! requirement!of!a! four!coordinate!geometry!as!being!a!key!structural! feature! for!
designing! a! metalVbased! antimalarial! (Sekhon! and! Bimal,! 2012).! Both! commonly!
used!quinolone!and!artemisinin!classes!of!drugs!have!been!proposed!to!interact!with!
metals! to!kill!malaria!parasites! through! freeVradical! intermediates! (Rasoloson!et*al.,!
2004).!
!
!Both! copper! and! iron! are! classified! as! reactive! metals! and! have! the! ability! to!
participate! in! the!Fenton! reaction.!The!Fenton! reaction! results! in! the!generation!of!
excessive!free!radicals!that!increase!oxidative!stress!and!increase!lipid!peroxidation.!
Under! normal! physiological! conditions,! copper! does! not! participate! in! Fenton!
chemistry,! however! when! bound! to! membraneVpermeant! copper! chelators,! it! may!
increase! its! redox!activity! to! induce!oxidative!damage! in!Plasmodium.! The!malaria!
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parasite! lacks! a! good! defense! mechanism! against! oxidative! stress,! as! such! the!





8VHydroxyquinolines! such! as! clioquinol! have! shown! great! potential! as! antiV
proliferative! agents,! as!well! as! in! the! field! of! neurodegenerative! diseases! such! as!
Alzheimer’s!disease! (Zhou* et*al.,! 2011).! !8VHydroxyquinolines!possess!antiVoxidant!
properties! and! are! lipophilic! chelates! that! have! been! reported! to! inhibit! RNA!
polymerase,! and! have! the! ability! to! chelate! both! copper! and! iron.! The! proposed!
mechanism! of! antimalarial! action! of! the! 8Vhydroxyquinolines! is! that! they! form!
complexes! with! iron! extracellularly! which! enters! the! infected! red! blood! cells! and!
rapidly!produces!a! lethal! free! radical!mediated! intracellular! reaction! (Mabeza!et*al.,!






QuinolinV8Vyl! derivatives! have! been! shown! to! possess! antiparasitic! properties! in!
leishmaniasis! and! trypanosomiasis! chemotherapy,! and! have! the! ability! to! form!
complexes! with! copper! and! zinc! (Da! Silva* et* al.,! 2007).! Although! they! possess!
antiparasitic! properties! in! leishmaniasis! and! trypanosomiasis,! formal! studies! to!








regards! to! antimalarial! activity.! Although! their! antimicrobial! activity! has! shown!








the! apparent! spread! of! resistance! has! created! a! great! need! for! research! into! the!
development! of! new! treatment! strategies! that!may! be! employed! to! target!malaria.!
The! knowledge! of! a! compound’s! mechanism! of! action! may! assist! in! the!





able! to! target!vital!processes! that!are!metal!dependent,!as!well!as!metal! ion!pools!
within!the!parasite!that!have!been!shown!to!be!more!susceptible!to!metal!starvation!
than! the! host! (Weinberg! and! Moon,! 2009).! Although! the! use! of! metal! chelating!
agents!in!malaria!is!not!a!new!concept,!there!is!a!need!to!reVvisit!and!reVdesign!the!
concept.!The!success!of!employing!chelating!agents! in! the! fields!of!cancer! therapy!
and!Alzheimers!disease!cannot!be!ignored,!and!thus!a!possible!approach!for!malaria!
therapy! would! be! to! explore! and! identify! agents! that! have! had! success! in! other!
diseases.! These! compounds!might! act! against! other! systems! found! in! the!malaria!
parasite! and! discover! new! targets! for! therapy.! If! the! possibility! of! discovering! new!















•! To!assess! the! in*vitro*properties!of! the!novel!aminoquinolines,!quinolinV8Vyl!and!
metal! complexes! of! thiomethyl! and!methylthiomethyl! aniline! derivatives! against!
the! asexual! parasite! and! determine! the! effect! of! combining! the! most! active!
compounds!with!quinine.!
!
•! To! investigate! the!mechanism! of! action! of! the! novel! compounds! by!monitoring!
oxidative!stress!pathways!within! the!parasite,! inhibition!of!haemozoin! formation,!
iron!and!copper!chelation!properties.!
!

























The! five! amminoquinoline! derivatives! and! six! quinolinV8Vyl! derivatives! were!
synthesised,!characterised!and!the!purity!and!validation!of!the!structures!completed!
by! Prof! J.! Bikash! Baruah! and! Prithiviraj! Khakhlary,! Indian! Institute! of! Technology,!
Assam,! India! (Appendix! A).! These! derivatives! were! synthesised! by! reacting! an!
amminoquinoline! and! respective! acid.! Using! XVray! single! crystal! diffraction! the!
structures!of!the!compounds!were!determined!and!characterised.!
!
A! total! of! 31! methyl(thiomethyl)aniline! compounds! and! 24! thiomethyl! aniline!
compounds!were!synthesised!and!characterised!by!Dr!G.!Watkins!and!Dr!D.!Beukes,!






mM!stock! solutions.!All! of! the! compounds!dissolved!easily! under! sterile! conditions!
and! as! such! no! physical! changes!were! required! such! as! heating,! in! order! for! the!
compounds!to!go!into!solution.!Once!dissolved!the!sterile!compounds!were!aliqouted!
into!small! volumes!and!stored!at! V20°C! to! increase! the!stability!of! the!solution!and!




at! 200! µM.! Absorbances! for! all! plates! were! determined! using! a! UVVVIS!
spectrophotometer! (Labsystems! iEMS! Reader! MF)! and! recorded! in! Ascent™!
software!version!2.6.!Thereafter,!the!results!were!analysed!and!compounds!showing!
potential! activity! of! greater! than! 50%! or! inhibition! more! than! 50%! were! studied!
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further.!Lead!compounds!were!serially!diluted!and!log!sigmoid!dose!response!curves!
were!generated! in! order! to! determine! the! concentration!of! the! compound!at!which!
there! was! 50%! inhibition! of! biological! activity! (IC50)! using! the! computer! software!






A! chloroquineVsensitive! 3D7! strain! of! P.* falciparum! was! cultured! in* vitro* and!
maintained!daily!according!to!the!method!described!by!Jensen!and!Trager!(1977).!A!
thin!blood!smear!of!the!culture!was!made!daily!and!fixed!using!100%!methanol!and!
then!stained!using!a! rapid! staining!diagnostic! kit! (Clinical!Sciences!Diagnostics)! to!
visualize! the! parasite! which! stained! the! parasites! purple,! which! allowed! for! easy!
detection.! The! slide! was! examined! under! oil! immersion! (1000x)! with! a! Nikon!
Optiphot! light! microscope! and! the!%! parasitaemia! and! stage! of! the! parasite’s! life!








Incomplete! media! used! for! culturing! purposes! consisted! of! 10.4! g! Roswell! Park!
Memorial! Institute! RPMIV1640,! 5.9! g! NV2VhydroxyethylVpiperazineVNV2VethaneV
sulfonic! acid! (HEPES),! 4! g! glucose,! 44!mg! hypoxanthine! and! 100! μl! of! 50!mg/ml!
gentamicin.!This!was!dissolved!1!L!in!sterile!Millipore™ water.!!Experimental!media!













Parasite! cultures! needed! to! be! predominantly! in! the! ring! stage! of! the! asexual! life!
cycle! in!order! to!complete! the!planned!experimental!protocols! (Jensen!and!Trager,!
1977).! Parasites! grown! in! culture! loose! their! natural! synchronicity,! as! such! they!
needed! to! be! treated! with! sorbitol! to! achieve! phase! synchronicity! (Lambros! and!
Vanderberg,! 1979).! Sorbitol! is! a! sugar! alcohol! that! has! the! advantage! of! inducing!
haemolysis!as!it!remains!osmotically!active!in!the!infected!red!blood!cell.!While!doing!
so,! it! is! not! metabolised! by! the! parasite! and! affects! mainly! the! trophozoite! and!
schizont!stages!of!asexual!development,!as!a!result!of!their!increase!in!red!blood!cell!
permeability!(Wagner*et*al.,!2003).!!
Cultures!with! a! high! percentage! of! parasites! in! the! ring! stage!were! centrifuged! at!
400g*for!5!minutes!and!the!supernatant!discarded.!The!pellet!was!incubated!at!37°C!
with! a! 5%! (w/v)! DVsorbitol! (SigmaVAldrich®)! for! 20! minutes.! Thereafter! the!
suspension!was!centrifuged!at!400g! for!5!minutes!and!the!pellet!was!reVsuspended!
in!incomplete!culture!media,!gassed!and!incubated!at!37°C.!The!5%!(w/v)!DVsorbitol!
solution!was!prepared!by!dissolving!5!g! in! 100!ml! of! autoclaved!Millipore™ water.!
The!solution!was!sterilised!through!a!0.22!µm!filter!and!stored!at!4°C!until!needed.!
2.2.5(Preparation(of(red(blood(cells(
Whole! blood! was! obtained! weekly! from! healthy! drug! free! volunteers! within! the!
Department! of! Pharmacy! and! Pharmacology! (Appendix! B1,! clearance! certificate!
number:! M140669)! and! stored! in! anticoagulant! tubes! containing! acid! citrate!
dextroseVB! solution.! The! red! blood! cells! (RBCs)! were! washed! after! collection! by!
centrifuging! at! 400g* for! 5!minutes,! the! buffy! coat!was! aspirated! and! the! pellet! reV
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a! radiolabeled! nucleic! acid! precursor,! hypoxanthine.!Within! the! RBCs,! the! malaria!
parasite! is!unable! to!synthesise!purines! that!are!essential! for!nucleic!acid!synthesis!







Parasites! mainly! in! the! ring! stage! of! the! life! cycle! were! treated! with! DVsorbitol!
(Section!2.2.4),!in!order!to!achieve!synchronicity.!A!GiemsaVstained!thin!blood!smear!
was!examined!microscopically.!A! total!of! ten! fields!were!examined!determining! the!
number! of! red! blood! cells! and! infected! RBCs.!%! Parasitaemia! of! the! culture! was!
calculated!using!Equation!2.1.!










were! diluted! in! incomplete! experimental! media! (10! times! dilution! factor).! The!
compounds!and!controls!were!serially!diluted!and!plated!out! in! triplicate! in!a!sterile!
96!well! plate! (Figure!2.1).!Row!H!was!considered!as! the!control! row,!with! the! first!
four! wells! used! as! a! RBC! control! and! the! last! eight! wells! used! as! the! drugVfree!
parasite! control,! where! 25! μl! incomplete! experimental! media! was! added! to! these!
wells! instead!of!drug.!A!volume!of!200!μl!of!a!1%!haematocrit!of!unVinfected!RBCs!
was! added! to! the! first! four!wells! of! row!H.! Thereafter,! 200!μl! of! the! infected!RBC!
suspension!was!added!to!the!remainder!of!the!plate.!The!plate!was!then!placed!in!a!






































incomplete!experimental!media!at!a! ratio!of!1:270.!Of! the! latter!solution,!25!μl!was!
added!to!all! the!wells!of!the!plates!and!reVincubated!for!a!further!24!hours!at!37°C.!
The![3H]VDNA!was!harvested!onto!glass!fibre!filter!mats!(Wallac™)!using!a!Titertek®(





% Parasite growth = CPMdrug  −  CPMmean  RBC controlCPMmean  parasite  control
 





During! the! course! of! this! study! the! Wallac™! beta! scintillation! counter! used! to!
quantify! the! antimalarial! activity! of! the! compounds! broke! down! and! was! made!
redundant.!Thus!requiring!an!alternative!means!of!quantifying!the!antimalarial!activity!
of! the! chosen! compounds! to! be! established.! Initially! the! sybr! green! 1! fluorescent!
assay! (Johnson* et* al.,! 2007)! was! established! and! validated! in! the! Pharmacology!
division.!All!compounds!were!screened!using!this!assay,!but!it!was!finally!decided!to!
use!the!parasite! lactate!dehydrogenase!(pLDH)!assay!(Makler*et*al.,!1998).! ! It!was!
observed! that! the! three! assays! generated! similar! results,! but! the! pLDH! assay!
generated! more! reproducible! results! and! was! less! intensive! for! highVthroughput!
evaluation!of!novel!compounds!than!the!sybr!green.!
2.3.2(Parasite(lactate(dehydrogenase(assay(for(drug(sensitivity(
The! pLDH! assay! for! drug! sensitivity! works! on! the! principle! that! host! lactate!
dehydrogenase! is! distinguishable! from! that! of! the! parasite! DH! when! using! the!
substrate!3Vacetyl!pyridine!adenine!dicunleotide!(APAD)!which!can!only!be!used!by!





Parasites! were! prepared! in! the! same! manner! as! the! tritiated! hypoxanthine!
incorporation!assay!(Section!2.3.1.1)!with!the!same!plate!setVup!with!the!exception!of!
Row!H,!where! the! first! three!wells!were! treated! as! a! blank! and! the! following! nine!
wells!as!a!drug!free!parasite!control!(Figure!2.2).!The!parasite!suspension!plated!out!
to! the! appropriate! wells! consisted! predominantly! of! the! ring! stage! with! a! 2%!
parasitaemia!and!2%!haematocrit.!A!volume!of!100!μl!parasitised!RBCs!in!complete!
experimental!media!was!plated!out!in!a!sterile!96!well!plate.!This!plate!was!incubated!
in! a! candle! jar! for! 24! hours! at! 37°C! (Section! 2.3.1.2)! without! the! addition! of! test!
controls!or!compounds.!Thereafter,!12.5!μl!of!the!test!compound!and!positive!control,!






μl! of! Malstat™! reagent! (Section! 2.3.2.2)! and! 20! μl! of! the! nitro! blue!




































Based!on! the!pLDH!assay,! the! two!most!active!compounds!were!studied! further! in!
combination!with!the!standard!antimalarial,!quinine.!Solutions!of!quinine!with!the!test!
compound! were! prepared! at! concentrations! 18! times! higher! than! the! final!
concentration! required! for! the! experiment! (Section! 2.3.2.1)! in! order! to! take! into!
account!for!the!nine!times!dilution!factor!of!the!experiment!and!the!two!times!dilution!
factor!of!combining!the!two!solutions!in!equal!volume.!


































Ratio( A( B( C( D( E( F( G( H( I(
X( 100! 100!! 50! 25! 2.5! 0.25! 0.025! 0.0025! 0!
Y( 0! 0.031! 0.31! 1.25! 5! 17.5! 25! 100! 100!
!
Based!on!the!IC50!values!of!the!combination!as!well!as!the!drug!alone,!relative!ratios!
or! fractional! IC50! values! (FIC50)! were! determined! (Equation! 2.4).! The! sum! of! the!
FIC50values! (ΣFIC50)! were! used! to! generate! isobolograms! (Figure! 2.3)! in! order! to!
determine!the!degree!of!interaction!between!the!compound!and!quinine!and!this!was!
categorized! as! being! additive,! synergistic! or! antagonistic! (Berenbaum,! 1989).!





alone compound of  value













synthetic! process! can! be! used! to! mimic! the! formation! of! haemozoin! in! the! food!
vacuole!of!the!parasite!(Egan,!2006).!!The!presence!of!haemozoin!in!the!food!vacuole!
of! the!malaria!parasite! is!significant!as! it! signifies! the!breakdown!of!haemoglobin!a!
food!source!for!the!parasite.!The!βVhaematin!inhibition!assay!was!used!to!determine!









A! volume! of! 12.5! μl! of! the! test! compounds! and! the! positive! control,! chloroquine!





the! wells! except! the! blank,! to! which! DMSO! was! added.! A! volume! of! 25! μl! of!
Millipore™ water!was!then!added!to!all!the!wells.!βVhaematin!formation!was!initiated!












After! a! 24! hour! incubation! period! at! 37°C,! the!DMSOVsoluble! solution! in! the!wells!





reaction! solution! was! read! at! 405! nm.! The! βVhaematin! inhibitory! effects! of! the!






















































































plate! in! quadruplicate! wells,! with! one! well! serving! as! a! colour! control! for! the!
compound.!!Row!H!(1V9)!served!as!a!100%!DPPH!control!and!H!(10V12)!a!blank!to!
which! 50!µl! DMSO!was! added.! Thereafter,! 200!µl! of! a! 96.16! μM!DPPH! solution!
prepared!in!HPLC!grade!methanol!was!added!to!all!wells!except!the!blank,!to!which!
200! µl! methanol! was! added.! The! DPPH! stock! prepared! in! HPLC! methanol! was!
stored!at! 4°C! in! the!dark! for! a!week.!The!plate!was! then! incubated! in! the!dark! at!
room! temperature! for!30!minutes.!Thereafter! the! reaction!solution!was! read!at!540!
nm.! The! free! radical! scavenging! effect! of! the! compounds! was! determined! using!
Equation!2.6.!%!Scavenging!effect!!!!=!!!!!
!!!!!!!!!!!!! (ABS100% control - ABSblank) - (ABScompound - ABSblank)  ABS100% control - ABSblank  x100 !
Equation(2.6:!Percentage!free!radical!scavenging!effect.!
2.4.2.3(Lipid(peroxidation(inhibition(assay(
The! lipid! peroxidation! inhibition! assay! measured! the! antiVoxidant! activity! of! the!







control! row!with!25!µl! of!DMSO!added! to!all! the!wells! (Figure!2.6).!This!was! then!
reacted!with! 125!µl! linoleic! acid! emulsion! in! all!wells,! except! the! blank! and! colour!
control! wells,! to! which! sodium! phosphate! buffer! was! added.! A! 2:1! suspension! of!
linoleic! acid! (102.4! µl)! and! TweenV20! (51.2! µl)! was! freshly! prepared! in! sodium!
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phosphate! buffer! (pH! 7.0),! which! consisted! of! 0.23! mM! NaH2PO4! and! 0.23! mM!
NaH2PO4.2H2O.!A!volume!of!100!µl!sodium!phosphate!buffer!(pH!7.0)!was!added!to!
all!wells!thereafter.!!The!mixture!was!then!shaken!at!600!rpm!using!an!orbital!shaker!












































a! direct! effect! on! the! parasite! or! the!RBC!membrane,! the! latter!would! indicate! an!
effect!on!the!host!cell!and!a!false!positive!for!antimalarial!activity!(Hayat*et*al.,!2011).!!
2.4.3.2(Experimental(protocol(
Chloroquine! and! quinine,! both! negative! controls! were! prepared! (10! times! dilution!
factor)! in! incomplete! experimental! media! (Section! 2.2.2)! and! plated! out! (20! µl)! in!
quadruplicate!into!a!sterile!96!well!plate!with!one!of!the!latter!four!wells!treated!as!a!
colour! control!well.!Row!H!was!used!as!a!control! row!with! the! first!half! of! the! row!
serving!as!a!0%!lysis!control!using!complete!experimental!media!and!the!second!half!
as!a!100%! lysis!positive!control!using!0.2%!(v/v)!TritonVX100!prepared! in!PBS!(pH!
7.2)! (Section! 2.2.5).! ! Thereafter,! 180! µl! of! complete! experimental! media! (Section!
2.2.2)! was! added! to! the! colour! control! wells.! A! 1%! haematocrit! of! washed! RBCs!
(Section! 2.2.5)! that! were! (not! older! than! three! days! to! ensure! the! optimal! RBC!





a! new!nonVsterile! 96!well! plate,! to!which! 150!µl!Millipore™ water!was! added.!The!

















The! 13V[4,5VdimethylthiazolV2Vyl]V2,5Vdiphenyltetrazolium! bromide! (MTT)! based!
cellular!viability!assay!utilizes!a!change!in!colour!as!an!expression!of!the!cleavage!of!
the!yellow!MTT!by!active!mitochondria!to!form!a!dark!blue!formazan!product!which!is!







The! cells! were! maintained! with! complete! Dulbecco’s! Modified! Eagle’s! Medium!
(DMEM)!culture!medium!(Section!2.4.3.6)!which!was!replenished!twice!a!week.!HEKV




cells!were!more! than! 80%! confluent.! These! cells!were!washed!with! PBS! (Section!
2.2.5)! and! thereafter! 3!ml! of! 0.25%! trypsin!0.1%!VersenseVEDTA! (SigmaVAldrich®)!
was!added!to!cover!the!cells.!After!5V10!minutes,!3!ml!complete!culture!medium!was!
added!to!detached!cells!to!neutralize!the!trypsin.!Based!on!the!experiment!schedule!










serum! (SigmaVAldrich®),! 1!ml! of! 200!mM!LVglutamine! (SigmaVAldrich®),! 1!ml! 0.026!
mM! carbapenicillin! and! 1! ml! 10! mM! sodium! pyruvate! (SigmaVAldrich®)! to! 100! ml!
incomplete! culture! medium! (Section! 2.4.3.2.4).! Foetal! calf! serum! (SigmaVAldrich®)!
was!thawed!to!room!temperature,!it!was!then!heat!inactivated!at!56°C!for!45!minutes,!
then!aliquoted!out!and!stored!at!V20°C!until!needed.!(
Complete! experimental! medium! consisted! of! the! same! components! with! the!
exception!of!carbapenicillin.!!
2.4.3.7(Experimental(protocol!
In! order! to! determine! the! cell! number/ml! in! the! suspension! the! trypsinized! cell!
suspension!(Section!2.4.3.4)!was!stained!in!a!1:1!ratio!with!sterile!0.2%!(w/v)!trypan!
blue!(SigmaVAldrich®)!in!PBS!(Section!2.2.5).!The!stained!cells!were!counted!using!a!
haematocytometer! and! light! microscope! at! 100x! magnification.! To! determine! the!
number!of!viable!cells!for!the!assay,!the!numbers!of!dead!cells!as!well!as!viable!cells!
were!noted.!Dead!cells!stained!blue!due! to! their! ruptured!membranes!and!as!such!
they!have! the!ability! to!absorb! the! trypan!blue!stain.!Whilst! live!cells!had!an! intact!
membrane!and!were!transparent!under!the!microscope.!!







in! incomplete! experimental! media,! 10! times! dilution! factor)! were! plated! out! in!
quadruplicate,!with!one!of! the! four!wells! serving!as!a! colour! control.! !The! last! row!
was!treated!as!a!100%!untreated!control!with!a!blank!in!the!first!three!wells,!to!which!








and! replaced! with! 150! µl! DMSO! to! dissolve! the! insoluble! formazan! crystals.! The!




% Cell  viability =
ABSdrug (540nm)  −  ABSdrug (690 nm)   
mean ABSdrug free control  (540nm)  −  mean ABSdrug free control  (690 nm)  





















A! human! erythromyeloblastoid! leukemia! cell! line,! namely! K562! was! cultured! and!
maintained! in* vitro! at!37°C! in!5%!CO2! in!a! tissue!culture! flask! fitted!with!a!porous!
membrane!on! the! lid,!according! to! the!established!departmental!protocol.!The!cells!
were!maintained!with!complete!DMEM!culture!medium!(Section!2.4.3.6)!in!a!similar!
manner!to!the!HEKV293!cells!(Section!2.4.3.4)!with!the!exception!of!the!subVculturing!
method.! The! K562! is! a! suspension! cell! line! and! as! such! there! was! no! need! to!




The! MTT! assay! was! used! to! determine! the! antiVproliferative! activity! of! the! test!




Iron! is! vital! to!both! the!host! as!well! as! the!malaria!parasite.!Parasites! require! iron!
from! their! host! for! processes! such! as! DNA! synthesis,! carbohydrate! metabolism,!
mitochondrial!function!and!electron!transport,!amongst!others!(Mabeza*et*al.,!1999).!
Due!to!the!parasite’s!obvious!need!for!iron!to!complete!lifeVsustaining!processes,!the!
use! of! an! iron! chelator! would! cause! “iron! starvation”,! thereby! inhibiting! essential!
metabolic!processes!and!killing!the!parasite!(Weinberg!and!Moon,!2009).!Ferrozine!
forms! complexes! with! Fe2+,! and! when! exposed! to! a! chelating! agent,! the! complex!















iron! chloride! (30!µl)! prepared! in! 649!µM!ammonium! acetate!was! added! to! all! the!









!!!!!! (ABS100% control - ABSblank) - (ABScompound - ABSblank)  ABS100% control - ABSblank  x100 !
Equation(2.10:(Percentage!Iron!chelation.!
2.4.5.3(Copper(chelation(assay((
The!copper! I!and!copper! II!assay!worked!on! the!principle!of!exposing! the!potential!
copper!chelator! to!a!solution!of!either!Cu1+!or!Cu2+!under!specified!pH!conditions!to!
ensure!the!stability!of!the!cationic!state.!The!assay!measured!the!potential!chelators!

















control! and! blank!wells,! to!which! 50!µl!Millipore™ water!was! added.! The! reaction!
solution!was! read!at!450!nm.!The!%!copper!chelation!was!calculated!according! to!
Equation!2.11.!%!Copper!chelation!I/II!=!!
(ABS100% control - ABSblank) - (ABScompound - ABSblank)  





to! prepare! a! working! 1! nM! Cu1+! solution! and! Millipore™ water! for! a! 1! nM! Cu2+!
solution.!
2.4.5.6(Experimental(protocol(copper((II)(




was!added!to!all! the!wells,! followed!by!100!µl!HEPES!buffer! (pH!6.8V7.5)! to!all! the!
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wells.!The!plate!was!then!incubated!in!the!dark!at!room!temperature!for!15!minutes.!















against!P.* falciparum!compared! to! their!cytotoxicity!using! the!HEKV293!cell! line,!by!




>10!were! regarded! as! nonVtoxic! (Zirihi* et* al.,! 2005)! (Equation! 2.11).! The! selective!
activity! of! the! compounds!against! the!HEKV293! cell! line! or! nonVcancerous! cells! as!
compared!to!the!K562!cell!line!or!cancerous!cells!were!determined!by!calculating!the!
selectivity! index! of! the! compounds.! A! SInc! (Equation! 2.12)! of! >10! was! considered!
more! favourable! towards! HEKV293! cells! and! a! SIn.c! of! <10! was! considered! more!
favourable!towards!K562!cells.!!!
! SIpf!= Cytotoxicity (IC50)Antimalarial activity (IC50) !!
Equation(2.11:!Selectivity!index!for!P.*falciparum!compared!to!HEKV293!cells!



























Historically! quinoline! based! antimalarials! have! been! at! the! forefront! of! malaria!
treatment!and!drug!discovery!dating!back! to! the!17th!century.!Prior! to!World!War! II!
compounds! such! as! quinine,! pamaquine! and! chloroquine! were! developed.! These!
were! followed!by!amodiaquine!and!primaquine.!Quinine!was! first! isolated! from! the!
Cinchona! tree! bark! in! the! late! 1600’s! and! during! the! 20th! century! chloroquine,! the!
most!widely!known!drug!from!this!group!provided!hope!for!eradication!of!the!disease!
that!plagued!society!since! the!age!of!Hippocrates!400!B.C!(Meshnick!and!Dobson,!
2001).! Pamaquine! was! the! first! 8Vaminoquinoline! antimalarial! used! in! combination!
with!quinine!and!was!able!to!target!the!parasitic!gametocytes!(Figure!3.1).!This!drug!
was! then! used! for! preventing! relapses! from! occurring! in! P.* vivax! infections!
specifically! during! the! liver! stage! of! the! disease.! A! relapse! infection! occurs! when!
dormant!liver!stage!forms!known!as!hypnozoites!become!active!and!differentiate!into!
merozoites,! which! burst! and! cause! a! bloodVstage! infection.! In! so! doing! the! 8V
aminoquinolines!have!the!unique!ability!to!exhibit!activity!on!gametocytes!as!well!as!
hypnozoites! (Waters! and! Edstein,! 2012).! ! Although! this! is! so,! pamaquine! showed!
little! effectiveness! against! bloodVinduced! infection,! as! such! it! was! a! poor! blood!






The! particular! manner! in! which! antimalarials! consisting! of! a! quinoline! scaffold!
produce! their! effect! is! not! completely! understood,! but! there! are! a! few! proposed!
mechanisms!of!action.!These!include!the!inhibition!of!protein!synthesis,!the!inhibition!




ability! to!act!during! the!blood!stages,!as!well! as! the!hepatic! stages!of! the!asexual!
stages! of! development! (Egan* et* al.,! 2000).! Chloroquine,! a! 4Vaminoquinoline!
derivative!is!proposed!to!be!specifically!active!against!the!process!during!which!the!
parasite! actively! degrades! haemoglobin! (Figure! 3.1).! In! order! for! the! parasite! to!
obtain! essential! amino! acids! needed! for! growth,! the! parasite! digests! the!





Although! compounds! consisting! of! a! quinoline! scaffold! have! proven! successful!
against!Plasmodium* infections,!the!threat!of!the!expansion!of!resistance!is!still!very!
real! with! resistance! developed! against! standard! antimalarials! such! as! chloroquine!
and! mefloquine! (WHO.,! 2015).! However! the! quinoline! backbone! still! provides! a!
starting!point!for!further!derivatisation!of!novel!antimalarial!compounds.!Thus!the!first!
set!of!compounds!used!in!this!study!were!structurally!similar!including!the!quinoline!
scaffold! and! comprised! of! a! series! of! salts,! adducts! of! 5Vaminoquinoline! and! 8V




















•! To!assess! the! in* vitro*properties!of! the!novel! aminoquinolines!and!quinolinV8Vyl!
derivatives! against! the! asexual! stages! of! the! parasite! using! the! tritiated!
hypoxanthine!incorporation!assay.!
•! To! investigate! the!mechanism! of! action! of! the! novel! compounds! by!monitoring!
oxidative! stress! pathways!within! the! parasite,! inhibition! of! haemozoin! formation!
as!well!as!iron!and!copper!chelation!properties.!













and! its! corresponding! hydroxyaromatic! acid.! Compound! I( was! formed! from! 5V
aminoquinoline! and! gallic! acid,! compound! II! from! 5Vaminoquinoline! and! 2V
hydroxybenzoic! acid,! compound! IV! was! formed! from! 8Vaminoquinoline! with! 1V
hydroxyV2Vnapthoic!acid!(Figure!3.2).!An!adduct!was!formed!for!compound!III(with!8V
aminoquinoline! and! gallic! acid.! In! general,! quinoline! interacts! with! aromatic!
carboxylic! acid! and! has! the! ability! to! form! hydrogen! bonded! adducts,! and! in!
aminoquinolines! there! are! two! potential! sites! to! act! as! hydrogen! bond! acceptors!
depending!on!the!acidity!of!the!carboxylic!acid!it! is! interacting!with.!Thus!they!have!
the!ability!to!either!form!a!hydrogen!bonded!adduct!or!hydrogen!bonded!salt.!A!salt!












































































exhibiting! potential! as! inhibitors! of! vascular! endothelial! growth! in! cancer! therapy.!
This!amide!has!various!unique!structural! features!such!as!two!distinguishable!ends!
for! supramolecular! reactions.! As! well! as! a! rotatable! amide! bond! which! allows! for!
various!packing!patterns! to! form!and!create!different!arrangements!within! its! lattice!
and! in! so! doing! allows! for! the! conversion! into! different! polymorphs! (Yang* et* al.,!
2010).!The!nitrogen!atom!present!on!the!quinoline!has!the!ability!to!act!as!a!proton!
acceptor!and!in!so!doing!has!the!ability!to!form!a!salt.!Compounds!S3(and!S5!were!
polymorphs! synthesized! from! 4VnitroVNV(quinolinV8Vyl)benazamide! by! reacting! 8V
aminoquinoline! and! its! corresponding! acid! chloride! (Khakhlary! and!Baruah,! 2014).!
Compounds! S1! and! S2! were! prepared! by! reacting! 8Vaminoquinoline! with!
bromoacetyl!bromide! followed!by! reacting! the!product!of! this! reaction!with!phenolic!
compounds! (Figure! 3.4).! Compound! S4! was! prepared! by! reacting! 1Vnapthyl!
isocyanate!with!a!mixture!of! 8Vaminoquinoline!and!compound!S6!was!prepared!by!
reacting!1Vnapthyl!isocyanate!with!a!mixture!of!5Vaminoquinoline.!XVray!single!crystal!











































































































3.2).!Of! the! 11! compounds! screened,! IC50!values!were! obtained! for! 5! compounds!
with! compounds! I( (IC50! value:! 25.1! ±! 1.3! μM)! and! V( (IC50! value:! 25.2! ±! 3.6! μM)!
displaying! the!highest!potential!activity!within! this!group.!Both!compounds! inhibited!
the!parasite!growth! to!a!similar!degree,!but!when!compared! to!quinine! (IC50!value:!
0.085!±!0.005!μM)!and!chloroquine!(IC50!value:!0.0065!±!0.0006!μM)!the!activity!was!
moderate.!The!order!of!decreasing!activity! for! the! five!compounds!against! the!3D7!
strain!is!as!follows:!I(>!V(>!II(>!III(>!IV.!
In! order! to! elucidate! a! possible! mechanism! of! action! as! described! for! the! 4V
aminoquinoline,! such! as! chloroquine,! the! inhibitory! effects! of! the! derivatives! were!
evaluated.!Compound!I(was!shown!to!possess!negligible!activity!to!inhibit!haemozoin!























































I( 6.38!±!0.97! 25.08(±(1.3( 10.76!±!1.86!
II! 27.13!±!2.22! 34.6!±!3.19! 0.10!±!0.01!
III! 69.16!±!3.19! 75.38!±!5.20! 0.10!±!0.01!
IV! 67.76!±!7.11! 104.09!±!16.52! 0.10!±!0.01!
V( 0.10!±!0.01! 25.19(±(3.62( 0.10!±!0.01!
S1! 76.54!±!6.14! n.d! 0.10!±!0.01!
S2! 76.76!±!4.48! n.d! 0.10!±!0.01!
S3! 80.87!±!3.44! n.d! 0.10!±!0.01!
S4! 79.45!±!12.47! n.d! 0.10!±!0.01!
S5! 95.44!±!2.36! n.d! 0.10!±!0.01!
S6! 85.24!±!5.70! n.d! 0.10!±!0.01!
Quinine! 0.068!±!0.003! 0.085!±!0.005! !!!!!!0.2!±!1!*!











The! safety! index! of! the! compounds! (SIpf)! that! displayed! antimalarial! activity! was!
determined! by! comparing! their! cytotoxic! activity! on! HEKV293! kidney! cells! to! their!
antimalarial!activity.!This!was!achieved!using!the!IC50!values!of!the!two!assays!as!a!
means! of! comparing! the! degree! of! effect! on! the! human! kidney! epithelium! and!
malaria! parasite.!Of! the! five! compounds! active! against!P.* falciparum,! compound! I!









cellular! viability! assay! on! a! K562! leukemic! cell! line! (Section! 2.4.4.2).! Two! of! the!
aminoquinoline!derivatives!displayed!slight!antiVproliferative!activity!when!compared!
to! the!positive!control!camptothecin!(IC50!value:!4.77!±!0.28!μM).!Compound! I( (IC50!



















































II! 3.64!±1.20! 55.39!±!6.55! 62.22!±15.14! >!1.44**! >1.00*!
III! 1.01!±!0.33! 52.96!±!3.57! 63.96!±!7.33! >!0.66**! >1.00*!






S1! 0.85!±!0.26! 51.44!±!2.15! 50.69!±12.33! >1.00**! >1.00*!
S2! 0.85!±!1.1! 51.63!±0.33! 47.82!±10.35! >1.00**! >1.00*!
S3! 0.38!±!0.25! 75.43!±!5.57! 52.02!±!6.68! >1.00**! >1.00*!
S4! 0.54!±!0.17! 53.88!±11.74! 85.28!±11.1! >1.00**! >1.00*!
S5! 0.06!±!0.24! 54.64!±14.68! 52.17!±14.6! >1.00**! >1.00*!
S6! 0.67!±!0.53! 52.17!±!6.87! 65.79!±!15.634! >1.00**! >1.00*!
Chloroquine( 2.09!±!0.59! n.d! n.d( n.d( n.d(












the! group! varying! between! 0.1%! and! 96.45%! (Table! 3.4).! The! 8Vhydroxyquinoline!










































































Two!of! the!aminoquinoline!derivatives!displayed! lipid!peroxidation! inhibition!activity!


























































None!of! the!compounds!screened! for! iron!chelation!activity!displayed!effective! iron!
chelation! activity.! Compound! V( showed! the! most! activity! within! the! group! at! an!


























































The! compounds! that! displayed! antimalarial! activity! against! the! 3D7! strain! were!
screened! for!activity!against!a!chloroquineVresistant!FCRV3!strain!using! the! tritiated!
hypoxanthine! incorporation! assay! (Section! 2.3.1)! and! compared! to! quinine! (IC50!
value:!0.17!±!0.03!μM),!as!well!as!to!the!3D7!strain!results!(Figure!3.7).!Overall!the!












I! 0.10!±!0.01! 0.97!±!0.12( 12.58!±!2.15!
II! 0.10!±!0.01! 1.49!±!0.21! 0.1!±!0.01!
III! 0.10!±!0.01! 4.55!±!0.59! 7.41!±!1.09!
IV! 0.10!±!0.01! 4.50!±!0.71! 9.36!±!1.22!
V( 22.38(±(4.96( 34.02(±(1.41( 37.07(±(0.45(
S1! 13.59!±1.77! 5.08!±!0.56! 8.02!±!1.18!
S2! 21.37!±!4.29! 2.02!±!0.66! 19.45!±!1.38!
S3! 0.10!±!0.01! 1.22!±!0.39! 4.6!±!1.28!
S4! 20.3!±!5.73! 1.00!±!0.10! 7.52!±!1.2!
S5! 18.57!±!4.64! 1.51!±!0.33! 27.9!±!8.58!
S6! 17.0!±!4.81! 4.51!±!0.15! 0.10!±!0.01!
EDTA( 64.55!±!8.39! n.d! n.d!
TTM( ( n.d! 93.95!!±!0.93! n.d!
TETA( n.d! n.d! 92.54!±!0.27!
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most! potent! activity! within! the! group! against! both! strains,! although! four! fold!more!
potent!against!the!FCRV3!strain!(IC50!value:!5.91!±!1.12!μM)!as!opposed!to!the!3D7!
strain! (IC50! value:! 25.1! ±! 1.3! μM).! Compound( I! is! a! salt! derived! from! 5V
aminoquinoline!and!gallic!acid!with!the!latter!a!benzoic!acid!derivative!which!belongs!
to! a! large! family! of! secondary! metabolites! known! as! polyphenols.! Polyphenolic!
compounds!are!divided!into!two!major!sub!groups,!flavonoids!and!phenolic!acids!that!
include!hydroxycinnamic!acids!as!well!as!hydroxybenzoic!acids.!!Polyphenols!are!an!




!Gallic! acid! has! proven! successful! in! other! protozoan! diseases! such! as!
Trypanosomacruzi! through! the! inhibition!of!cellular! respiration!(Cortes*et*al.,!2015).!
Another! proposed! mechanism! in! which! gallic! acid! inhibits! the! formation! of!
Trypanosomacruzi* is! through! ROS! which! may! be! involved! in! gallic! acidVinduced!
apoptopic!cell!death!(Kayser*et*al.,!2002).!Studies!have!shown!that!gallic!acid!and!its!
derivatives!display!antimalarial!activity!against!a!3D7!strain!of!P.*falciparum*(Ndjonka!
et! al.,! 2012).! Although! the! precise! mechanism! in! which! gallic! acid! produces! its!
antimalarial!effect!has!not!been!not!defined,! the!proposed!mechanism!of!action!by!









































































potent! against! the! FCRV3! strain! (Figure! 3.7).! 8VHydroxyquinolines! are! known! to!
produce! an! antimalarial! effect! through! their! ability! to! chelate! iron! and! essentially!
starve! the!malaria! of! iron! and! copper,!which! it! needs! for! life! sustaining! processes!
such! as! DNA! replication! amongst! other! things! (Van! Vuuren! and! Van! Zyl,! 2014).!
Primaquine,! an! 8Vaminoquinoline! derivative! is! used! as! an! antimalarial! and! the!
proposed! mechanism! of! action! is! through! the! production! of! highly! reactive!
metabolites,!thereby!increasing!oxidative!stress!(Vale*et*al.,!2009).!RingVsubstituted!
8Vaminoquinoline!derivatives!have!been!shown!to!display!potent!antimalarial!activity!
(IC50:! 39ng/ml)! superseding! that! of! chloroquine! (Jain* et* al.,! 2004).! Antimalarial!
activity! studies!completed!on!chloroquineVresistant!as!well!as!chloroquine!sensitive!
strains! revealed!8Vhydroxyquinoline!was!more!effective! than! chloroquine,! by! totally!
inhibiting!the!parasite!growth!at!1!μM!(Biswas,!2003).!!Compound(V!is!composed!of!
two! components,! an! 8Vhydroxyquinoline! which! has! proven! to! display! potent!














nature! of! the! digestive! food! vacuole! of! the! parasite! provides! a! pharmacological!
parameter! for! the!sensitivity!of! this!drug! target.!Studies!have!shown! that! there! is!a!




the! pharmacological! properties! of! the! compounds! relating! to! pH! as! a! means! of!







target! for!antimalarial!activity! (Müller,!2004).!Ascorbic!acid,!a!known!antiVoxidant! in!
humans!is!known!to!exert!a!proVoxidant!effect!on!PlasmodiumVinfected!RBC’s.!ProV
oxidant!drugs!cause!the!increased!production!of!oxygen!radicals!inside!the!infected!
RBC,! as! well! as! to! leave! the! parasite! more! prone! to! attack! by! oxygen! radicals!
(Winter* et* al.,! 1997).! The! manner! in! which! proVoxidant! drugs! would! produce! an!
antimalarial!effect! is!directed!at! the!parasites’!digestive! food!vacuole.!RedoxVactive!
iron! is!generated!within! the!digestive! food!vacuole!as!haemoglobin! is!digested!and!
amino!acids!are!produced!for!protein!synthesis.!The!proVoxidant!drug!would!serve!to!
reduce! iron! to! its! ferrous! state,! oxygen! to! hydrogen! peroxide! and! the! resultant!





Primaquine,! an! 8Vaminoquionline! derivative! is! used! in! the! treatment! of! P.* vivax!
infections.! The!mechanism! of! action! by! which! it! produces! its! antimalarial! effect! is!
through! its!metabolism!producing! reactive!metabolites! that! result! in! the!build!up!of!
free! radicals,! hydrogen! peroxides! and! superoxides,! which! disrupt! the! redox!
equilibrium!and! cause! an! increase! in! oxidative! stress! on! the! parasite! (Waters! and!
Edstein,! 2012).! Previous! studies! on! 5Vaminoquinolines! using!mice! infected!with!P.*
berghei*revealed!that!the!5Vaminoquinoline!scaffold!is!unable!to!produce!an!inhibitory!
effect! on! malaria! parasite! growth! at! the! highest! dosage! level! tested,! 640! mg/kg!
(Khan!and!Lamontagne,!1979).!As!such!one!could!deduce!the!role!gallic!acid!would!
play! in! the! salt,! Compound( I,! composed! of! gallic! acid! and! 5Vaminoquinoline! in!
contributing! towards! the! inhibition! of! parasite! growth! against! both! the! FCRV3! (IC50!
value:!5.91!±!1.12!μM),!as!well!as!the!3D7!strain!(IC50!value:!25.1!±!1.3!μM)!through!
a!proposed!proVoxidant!mechanism!of!action.!Plant!species!composed!of!gallic!acid!








display! specific! activity! targeted! at! the! infected! RBC’s! as! opposed! to! uninfected!
RBC’s!of!the!host.!Haeme!is!an!ironVcontaining!component!part!of!haemoglobin,! its!
hydrophobic!nature!allows! for!easy!access! into! cellular!membranes!and!as!such! it!
has!the!ability!to!compromise!vascular!cell!integrity.!The!consequences!of!this!have!
been!linked!to!various!pathological!conditions!(Jeney*et*al.,!2002).!Therefore!careful!










potent! than!Trolox™.! The! same! compounds! displayed! antiVoxidant! activity! through!
the! inhibition! of! lipid! peroxidation! (Table! 3.5).! Although! both! compounds! displayed!
antiVoxidant!activity!they!both!expressed!this!activity!through!their!ability!to!scavenge!
free! radicals,! rather! than! through! the! inhibition! of! lipid! peroxidation.! When!







8VHydroxyquinolines! are! one! of! the! most! significant! derivatives! of! quinoline,! and!
have!proven!successful!in!a!variety!of!diseases!such!as!Mycobacterium*tuberculosis,!
Escherichia*coli,!as!well!as!displaying!antiviral!activity!and!antiVinflammatory!activity.!
Novel! 8Vhydroxyquinoline! derivatives! have! proven! successful! as! antiVoxidants!
employed! in! the! treatment! of! alzheimers! disease! (Prachayasittikul* et* al.,! 2013).! 8V
Hydroxyquinolines!participate! in! radical! scavenging! reactions!as!electron!donors!of!
hydroxyl! groups! to! form! stable! radicals.! The! antiVoxidant! mechanism! of! action! 8V
hydroxyquinolines! displays! is! dependent! on! the! stability! of! the! phenoxyl! radical!
formed!within! in! the! reaction! as!well! as! the! positioning! of! substituents,!which!may!
effect!the!stability!and!action!of!the!phenoxyl!radical.!According!to!studies!conducted!







Gallic!acid! is!a!known!antiVoxidant! in!emulsion!and! lipid!systems!as!well! as!a! free!
radical! scavenger,! and!has!been!known! to! show!stronger!antiVoxidant!activity! than!
several!waterVsoluble!antiVoxidants!such!as!ascorbic!acid!(Yilmaz!and!Toledo,!2004).!
The!neighbouring!positioning!of!the!three!hydroxyl!groups!in!the!aromatic!ring!allows!
this! molecule! to! interfere! with! the! redox! equilibrium! that! involves! the! formation! of!
quinoid! products! as! a! result! of! their! oxidation! (Serrano* et* al.,! 1998).! Although!
structurally! similar! in! that! both! compound( I! and! compound( III! are! composed! of! a!
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known! antiVoxidant,! gallic! acid,! the! adduct! formed! from! gallic! acid! and! 8V
aminoquinoline! proved! a! stronger! antiVoxidant! than! the! salt! it! formed! with! 5V
aminoquinoline.!Various!potent!antioxidants!such!as!ascorbic!acid,!as!well!as!other!






In! this! circumstance! with! regards! to! the! chemical! structure! of! compound( I! and!
compound( III!one!cannot! ignore! the!difference! in! the!manner! in!which!a!salt!would!
react! during! an! oxidation! reaction! as! oppose! to! a! coVcrystal.! During! the! reaction!
between!an!organic!acid!and!organic!base!the!outcome!as!to!whether!a!salt!or!coV







and! in! compound( III! there! was! no! proton! transfer! from! gallic! acid! to! 8V













acid! within! the! crystalline! structure! had! little! effect! on! the! pharmacological!
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mechanism!of!action!with!regards!to!its!proVoxidant!and!antiVoxidant!nature.!!The!use!
of! a! coVcrystal! structure! allows! two! separate! components! to! combine! chemically!
through! nonVcovalent! interactions! such! as! hydrogen! bonding,! van! der! Waals!
interactions! as! well! as! πVπ! stacking.! The! use! of! multicomponent! systems! within!
pharmacology! has! gained! interest! as! it! provides! a! means! of! improving! on!
physiochemical! properties! of! parent! compounds! such! as! increased! solubility! and!
stability.!Although! this! is! true,! the!physical!and!chemical!properties!of! the! resultant!
crystal,!as!well!as!whether!an!actual!crystal!could!be!formed!between!two!separate!
entities! cannot! be! predicted! and! further! studies! on! each! coVcrystal! formed! would!


















Oxidative! stress! and! the! production! of! ROS! has! been! tightly! linked! to! the!
development!of! cancer.!This! is!as!a! result! of! two!possible!mechanisms,! firstly,! the!
induction!of!gene!mutations!as!a!consequence!of!cell!injury,!and!secondly!the!effect!










The! proVoxidant! mechanism! of! action! theorized! with! regards! to( compound( I( and!
compound(V!could!be!applied!in!this!instance!as!well,!as!it!would!explain!the!effect!
on!both! the!HEKV293!cell! line!as!well!as! the!K562!cell! line.!Studies!on!gallic!acids!
ability! to! prevent! cell! proliferation! has! resulted! in! various! possible!mechanisms! of!
action,! on! different! types! of! cancer! cell! lines.! These! include! cell! death! occurring!
according! to!DNA! fragmentation! in! a!mouse! cell! lymphoma!Wehi! 231! cell! line,! as!






















the! expression! of! pharmacological! mechanisms! of! action! that! could! be!
explained!by!one!of!the!components!making!up!the!salt.!
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•! !Compound( I!and!compound( III!both!composed!of!gallic!acid!displayed!a!proV
oxidant!effect! in! its!salt! form,!and!a!potent!antiVoxidant!effect! in! its!coVcrystal!
form,!formed!with!5Vaminoquinoline!and!8Vaminoquinoline!respectively.!
•! !Compound( I! and! compound( II! proved! that! using! gallic! acid! in! place! of! 2V
hydroxybenzoic!acid!when! forming! the!salt!with!5Vaminoquiniline!allowed! for!
slightly!improved!antimalarial!activity.!!
•! Compound( V!displayed!antimalarial!activity!attributed! to! its!8Vaminoquinoline!
component,! and! expressed! potent! antiVoxidant! activity! as! a! result! of! its! 8V
hydroxyquinoline!component.!
•! With! regards! to! the! aminoquinoline! derivatives! used! in! the! study,! the!
antimalarial!activity!of!the!salts!and!coVcrystals!formed!was!not!as!potent!when!
compared!to!the!parent!compounds!making!up!the!salt!or!coVcrystal,!as!such!































secretion! and! is! maintained! with! strict! limitations.! Metal! ion! transporters! assist! in!
maintaining! the! required! levels! of! the! various! metal! ions! in! the! different! cellular!
compartments.!Metals!such!as!copper,!cobalt,!zinc,!iron!and!manganese!take!part!in!
various!metabolic!and!signaling!pathways!in!the!human!body!(Tapiero*et*al.,!2003).!
Copper! is! present! in!most! living! organisms! in! the! forms!Cu(I)! and!Cu(II),! with! the!
bivalent! form!being! the!most!stable!oxidative!state.!Copper! is!essential! to!all! living!
organisms!as! it!acts!as!a!coVfactor! for! several!proteins!and!enzymes! involved! in!a!
variety! of! biological! processes! such! as! respiration,! and! mechanisms! involved! in!
protection! from! oxidative! stress! (Bertini! and! Cavallaro,! 2008).! Cobalt! is! a! natural!
earth!element!that!has!trace!amounts!present! throughout!our!environment,!with!the!
most! common! oxidation! numbers! of! +2! or! +3.! Cobalt! is! considered! an! essential!
element! since! the!body! is! unable! to! synthesize! it.!Cobalt!makes!up!4%!of! vitamin!
B12!that!is!needed!for!the!development!and!initial!myelination!of!the!central!nervous!
system.! Nickel! is! a! metal! found! in! several! oxidative! states,! although! the! most!
common!in!biological!systems!is!the!+2!state.!Soluble!nickel!such!as!nickel!carbonyl!













resistance! to! standard! antimalarials! such! as! chloroquine.! Studies! have! proven! the!
potential!of! coordination!of! transition!metals! to!chloroquine! to! improve! the!effect!of!
the!standard!antimalarial!and! in!so!doing!overcome!resistance! (Sekhon!and!Bimal,!
2012).! The! introduction! of! copper! into! the! formation! of! alkyl! ligands! such! as!
hydroxynathoquinone! ligands!was! found! to! be!beneficial! to! the!antimalarial! activity!
against!chloroquineVresistant!strains!of!P.*falciparum*(Gokhale*et*al.,!2006).!The!use!
of! coordinating! nickel! to! an! aromatic! sulphur! containing! ligand! has! proven! to! be!
effective!against!P.*berghei! ! (Tella!and!Obaleye,!2011).!Cobalt! (III)!complexes!with!
chloroquine!revealed!the!metal!complex!was!more!effective!against!the!K1!strain!of!
P.*falciparum,*as!well!as! less!toxic!(Ajibade!and!Kolawole,!2010).!When!comparing!





transition!metal! complexes!with! variable! structures,! the!ability! to! select! and!modify!
the! ligands!affinities!according! to!electron! transfer,! substitution! rates!and! reduction!
potential! (Biot* et* al.,! 2012).! Metal! complexes! have! also! allowed! researchers! to!
explore! the! biological! effects! of!metals! in! the! organisms! being! studied! in! order! to!
develop! efficient! biological! targeting! methods! (Biot* et* al.,! 2012).! When! focusing!
specifically! on!metalloantimalarials,! the!metal! coordination! has! proven! to! enhance!
pharmacological,! as! well! as! chemical! properties! such! as! potency,! selectivity,!
chemical! stability! and! lipophilicity! (Bahl* et* al.,! 2010).! When! developing! metal!





the! ability! to! act! as! coordinating! ligands! due! to! the! presence! of! the! nitrogen,!
thioethersulphur! and! aniline.! The! presence! of! nitrogen! and! sulphur! create! a! hard!
borderline! and! soft! nature! that! permits! the! formation! of! stable! complexes! between!
them!and!metal!ions!and!have!found!application!as!intermediates!in!the!production!of!
many! organic! compounds.! In! many! biologically! active! organic! compounds! donor!
groups!such!as!nitrogen,!oxygen,!sulphur!and!chlorine!are!commonly!found!and!used!
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coordinated! to! alkylthioalkylated! anilines! could! prove! useful! with! regards! to! the!
obstacles! which! has! hindered! malaria! eradication,! as! such! novel!




•! To! assess! the! in* vitro* properties! of! the! novel! methyl(thiomethyl)aniline! and!
thiomethyl!aniline!metal!bound!chelates!against!the!asexual!stages!of!the!parasite!
and! to! determine! the! resultant! effect! of! combining! the!most! active! compounds!
with!quinine!using!the!pLDH!assay.!
•! To! determine! preliminary! toxicological! properties! of! the! compounds! against!
human!red!blood!cells!and!human!kidney!epithelium.!
•! To! investigate! the!mechanism! of! action! of! the! novel! compounds! by!monitoring!














































































Chemical(formula( Bound(ligands( Chemical(formula( Bound(ligands(
2MT( ! 2MA( !
Cu2MT! R!=!Cu! Cu2MA! R!=!Cu!





















pBr2MT! R1!=!Br! 4Br2MA! R1!=!Br!






















pMe2MT! R1!=!CH3! 4Me2MA! R1!=!CH3!

















pMeO2MT! R1!=!OCH3! 4MeO2MA! R1!=!OCH3!





















































All! of! the! compounds! displayed! significant! antimalarial! activity! when! compared! to!
quinine! (p! <! 0.05)! (Figure! 4.2).! At! 50! μM! there! was! a! range! of! parasite! growth!
between! 7.08%! and! 101.44%! (Table! 4.2).! From! the! MT! and! MA! groups,! both!
methoxy! substituted! compounds,! CupMeO2MT! (IC50! value:! 2.66! ±0.12! μM)! and!
Cu4MeO2MA! (IC50!value:!2.82!±!0.38!μM)!displayed! the!most!promising!activity!by!
inhibiting!parasite!growth!to!a!similar!degree!when!compared!to!quinine!(Figure!4.3).!
The! inhibition! of! haemozoin! formation! was! not! a! feature! of! the! compounds! when!




























































































































150 Quinine!(IC50: 0.0964 ±!0.0025 µM)
CupMeO2MT!(IC50:!2.66 ±!0.12 µM)
























































2MT( 97.62!±!6.16! n.d! 0.10!±!0.01!
Cu2MT! 24.0!±!5.14! 9.26!±!0.33! 0.10!±!0.01!
Co2MT! n.d! n.d! 0.10!±!0.01!
pCl2MT! 101.44!±!7.87! n.d! 0.10!±!0.01!
CupCl2MT! 25.51!±!4.99! 17.17!±!1.83! 0.10!±!0.01!
CuoCl2MT! 24.52!±!4.23! 23.92!±!0.89( 0.10!±!0.01!
CopCl2MT! n.d! n.d! 0.10!±!0.01!
pBr2MT! !!!!!101.38!±!4.26! n.d! 13.74!±!3.63!
CupBr2MT! 33.93!±!1.89! 18.22!±!1.75! n.d!
CuoBr2MT! 24.99!±!7.48! 49.99!±!2.04! 0.10!±!0.01!
CopBr2MT! n.d! n.d! 0.10!±!0.01!
CooBr2MT! n.d! n.d! 0.10!±!0.01!
oNO2MT! n.d! n.d! 0.10!±!0.01!
CupNO22MT! n.d! n.d! 0.10!±!0.01!
CopNO22MT! n.d! n.d! 0.10!±!0.01!
pMe2MT! 87.25!±12.45! n.d! 8.35!±!3.33!
oMe2MT! 89.31!±!4.95! n.d! 0.10!±!0.01!
CopMe2MT! n.d! n.d! 0.10!±!0.01!
CooMe2MT! n.d! n.d! 0.10!±!0.01!
CupMe2MT! 21.5!±!4.92! 6.02!±!0.66! 0.10!±!0.01!
CuoMe2MT! 20.5!±!9.16! 13.4!±!0.05! 0.10!±!0.01!
pMeO2MT! 88.08!±!8.90! n.d! 0.10!±!0.01!
oMeO2MT! 89.31!±!4.95! n.d! 0.10!±!0.01!
CopMeO2MT! n.d! n.d! n.d!
CupMeO2MT( 19.48!±!6.41! 2.66(±(0.12( 6.75!±!0.58!
CuoMeO2MT! 7.08!±!0.91! 10.92!±!1.46! 0.10!±!0.01!
NioMeO2MT! n.d! n.d! 0.10!±!0.01!
NipMeO2MT! n.d! n.d! 0.10!±!0.01!
CooMeO2MT! n.d! n.d! 11.56!±!3.32!
2MA! 97.69!±!10.42! n.d! 4.08!±!0.88!
Cu2MA! 12.39!±!4.23! 12.9!±!0.39! 13.57!±!4.05!
Co2MA! n.d! n.d! 0.10!±!0.01!
4Cl2MA! !94.52!±!11.95! n.d! 7.03!±!2.46!
6Cl2MA! 96.14!±!9.32! n.d! 13.18!±!3.46!
Cu4Cl2MA! 22.51!±!7.19! 10.07±!1.29! 9.12!±!2.55!
Cu6Cl2MA! 34.97±!9.17! 25.19!±!8.15! 0.10!±!0.01!
Co4Cl2MA! n.d! n.d! 0.10!±!0.01!
4Br2MA! !96.81!±!10.54! n.d! 7.66!±!1.08!
Cu4Br2MA! 37.47!±!3.23! 5.35!±!1.20! 0.10!±!0.01!
Cu6Br2MA! 41.71!±!7.79! 57.5!±!9.93! 0.10!±!0.01!
4Me2MA! 97.15!±!9.93! n.d! 7.02!!±!2.08!
6Me2MA! 98.09!±!9.14! n.d! 16.31±!5.4!
Co4Me2MA! n.d! n.d! 0.10!±!0.01!
Cu4Me2MA! 21.29!±!4.01! 18.0!±!1.40! 14.67±1.51!
Cu6Me2MA! 18.53!±!2.31! 15.79!±!1.65! 0.10!±!0.01!
4MeO2MA! !84.37!±!15.33! n.d! 20.99(±(3.22(
6MeO2MA! !81.82!±!11.01! n.d! 14.02!±!4.30!
Co4MeO2MA! n.d! n.d! 7.48!±!4.24!
Cu4MeO2MA! 19.27!±!4.55! 2.82(±(0.38( 0.10!±!0.01!
Cu6MeO2MA! 24.44±!3.57! 11.44!±!1.53! 0.10!±!0.01!
Ni6MeO2MA! n.d! n.d! 9.2!±!6.77!
Ni4MeO2MA! n.d! n.d! 0.10!±!0.01!
Co6MeO2MA! n.d! n.d! 9.13!±!4.39!
Quinine( 19.5!±!0.16! 0.0964!±!0.002! n.d!






CupMeO2MT! yielded! a! ΣFIC50! =! 1.56! which! is! indicative! of! an! antagonistic!
interaction! (Figure!4.4).!The!combination!of!quinine!and!Cu4MeO2MA!also!yielded!
an!antagonistic!interaction!with!a!ΣFIC50!=!1.38!(Figure!4.5).!













































Of! the! total! compounds!screened! for! toxicity!on!nonVcancerous!cells! from!both! the!
MT!and!MA!groups,!five!MT!derivatives!and!four!MA!derivatives!displayed!an!effect!
on! cell! viability! and! resulted! in! a!%! cell! viability! of! <50%.!CupMe2MT! (IC50!value:!
11.23!±!2.86!μM)!was!identified!as!the!most!toxic!compound!from!the!MT!group,!and!
Cu4MeO2MA( (IC50!value:!46.97!±!10.32μM)!was! the!most! toxic!compound! to!nonV
cancerous!cells!in!the!MA!group!when!compared!to!camptothecin!(IC50!value:!0.11!±!
0.01μM)!(Appendix!Cf!Table!C1,C2)!Overall!when!comparing!the!two!groups!the!MT!
derivatives! were! found! to! be! more! toxic! than! the! MA! derivatives! (Figure! 4.6).!
CupMe2MT!was!found!to!be!four!times!more!toxic!than!Cu4MeO2MA!and!100!times!










were! therefore! considered! nonVtoxic! to! human! cells,!with!Cu4MeO2MA! being! less!































When! screened! for! antiVproliferative! activity! on! a! leukemic! K562! cell! line,! five!MT!
derivatives! and! two! MA! derivatives! displayed! activity! when! compared! to!
camptothecin! (IC50! value:! 4.8! ±! 0.3μM)! (Appendix! C:! Table! C2)! (Figure:! 4.6).!
CupMeO2MT( (IC50!value:!12.25!±!1.97!μM)!was! found! to!be! the!most!active! in! the!
MT! group,! although! three! fold! less! potent! than! camptothecin.!Cu2MA( (IC50! value:!


































































































compounds! effect! on! normalized! kidney! cells! as! opposed! to! leukemic! cells! (Table!
4.4)! (Section!2.5).!Compounds! from!both! the!MA!and!MT!groups!displayed!activity!
against! both! cell! lines,! with! the! exception! of!Cu6Me2MA! and!Cu6MeO2MA! only!





































































50!μM.!Of! the!53!compounds!screened,! four! compounds!all! from! the!MA!group!of!
derivatives! showed! favourable! activity! when! compared! to! the! positive! control!
Trolox™( (IC50!value:!19.15!±!1.14!μM)! (Appendix!C:!Table!C4).!Ni4MeO2MA( (IC50!
value:! 9.63! ±! 0.69! μM)! was! twoVfold! more! potent! than! Trolox™( (Figure! 4.8)! at!









The! lipid! peroxidation! inhibition! activity! of! the! compounds! was! determined! at! a!




of! the! MT! group! and!Cu4Cl2MA( (IC50! value:! 6.57! ±! 1.71μM)! displaying! the! most!
favourable! activity! of! the! MA! group! (Figure! 4.9).! When! compared! to! the! positive!
control,! the! compounds! did! not! display! any! significant! activity! (p! ≥! 0.1).!When! the!

















































































































































































were! selected! to! complete! iron! chelation! activity! studies.! Of! the! 18! compounds!
examined!none!of! them!displayed! favourable! iron!chelation!activity!with!a! range!of!






complete!copper!chelation!studies!on!by!examining! their!ability! to!chelate!copper! I!










































When! examining! the! structural! differences! between! the!MT! and!MA! groups,! it! is!
important! to!note! the!only!variation!between! the!base!compounds!of! two!groups! is!











2MT! 14.77!±!2.05! 2.74!±!0.47! 1.94!±!0.5!
pMe2MT! 16.57!±!6.29! 2.70!±!0.12! 6.87(±(0.41(
oMe2MT( 18.38(±(4.64( 1.43!±!0.29! 1.59!±!0.14!
pMeO2MT! 13.2!!±!2.85! 2.29!±!0.29! 3.13!±!0.37!
OMeO2MT! 18.09!±!4.29! 1.44!±!0.17! 3.48!±!0.29!
pCl2MT! 14.1!±!2.85! 2.61!±!0.14! 1.63!±!0.39!
oCl2MT! 13.78!±!2.53! 3.20!±!0.48! 2.90!±!0.68!
pBr2MT! 14.88!±!2.36! 4.04(±(0.70( 3.28!±!0.36!
oBr2MT! 12.09!±!2.29! n.d! n.d!
oNO22MT! 13.42!±!0.76! 1.45!±!0.34! 2.52!±!0.69!
2MA! 12.44!±!1.82! 1.35!±!0.25! 1.00!±!0.13!
4Me2MA! !!!7.9!±!3.72! 0.48!±!0.13! 0.10!±!0.01!
6Me2MA! !!!4.5!±!0.57! 0.10!±!0.01! 0.10!±!0.01!
4MeO2MA! 15.17±!1.48! 0.10!±!0.01! 1.51!±!0.44!
6MeO2MA! 9.78!±!3.5! 0.10!±!0.01! 0.10!±!0.01!
4Cl2MA! 16.75!±!4.32! 0.10!±!0.01! 0.10!±!0.01!
6Cl2MA! 9.94!±!3.06! 2.03!±!0.23! 4.08!±!0.86!
4Br2MA! !!!!15.42!±!2.4! 0.54!±!0.18! !
EDTA! 79.29!±!17.85! n.d! n.d!
TTM! ! n.d! 93.95!±!0.93! n.d!
















is! the! chelation! of! copper! into! the! base! ligands! for! both! the!MT( and!MA( groups!
resulted!in!the!enhanced!antimalarial!activity!in!all!instances.!For!example!at!50!μM!
the! base! compound! 2MT! displayed! 97.62%! parasite! growth,! and! the! chelation! of!
copper!into!the!base!compound!resulted!in!a!substantial!decrease!in!parasite!growth!
to!24%!(Table!4.2).!When!comparing!the!activity!of!the!compounds!between!the!two!
groups,! differences! in! activity! where! seen! in! compounds! chelated! to! copper! and!
substituted! with! a! methylene! group! (CH3)! at! the! para! position,! for! example,!




2.82!±! 0.38!µM)! displayed! the!most! potent! antimalarial! activity! (Table! 4.2).! These!



















The! MT! and! MA! derivatives! that! displayed! antimalarial! activity! against! the!
chloroquineVsensitive! 3D7! strain! were! assessed! for! activity! against! a! chloroquineV
resistant!FCRV3!strain!using!the!titriated!hypoxanthine!incorporation!assay!(Prof!R!L!
van!Zyl!personal!communication)! (Figures!4.10,!4.11).!When!comparing! the!overall!
activity! of! the! two! groups! of! derivatives! to! the! two!different! strains,! the!majority! of!
compounds!displayed! slightly!more! favourable!antimalarial! activity! against! the!3D7!







































































































































































































































Although! the! majority! of! compounds! favoured! the! 3D7! strain,! the! most! active!




the! two! groups! against! the! two! different! strains,!CupMeO2MT! (IC50! value:! 2.66! ±!
0.12(µM)!was! the!most!active!against! the!3D7,!whereas!Cu4MeO2MA! (IC50!value:!
1.61!±!1.1!µM)!was!the!most!active!against!the!FCRV3!strain.!
!
The! compounds! displayed! similar! activity! against! the! FCRV3! strain! regardless! of!
whether!substituents!were!bound!at!the!ortho!or!para*position,!with!the!exception!of!









mechanisms! in! the! malaria! parasite! (Choveaux! and! Goldring,! 2010).! Due! to! the!
necessity!of! copper! in! the!body!of! the!host,! the! role! it! plays! in!disease!states!has!
been!studied!extensively!(Tapiero*et*al.,!2003).!The!buildVup!of!copper!and!disruption!
in! copper!homeostasis!has!been! linked! to! the!development!and!aggregation!of!Aβ!
peptide,! which! leads! to! amyloid! formation! and! the! progression! of! Alzheimers!
disease.!The!use!of!copper!chelators!has!proven!successful!in!this!regard!(Sabayan*
et* al.,! 2010).! In! addition,! the! use! of! a! copper! complex,!Cu(II)VgammaVpolyglutamic!
acid! has! been! shown! to! mimic! the! action! of! insulin! for! potential! use! in! diabetic!
treatment!(Karmaker*et*al.,!2007).!!
!
Although! these! trace!metals!are!essential! for! essential! life! sustaining!processes! to!




copper! necessity! and! toxicity! is! governed! by! homeostasis! transport! mechanisms,!
compartmentalization!and!binding!capabilities!at!tissue!and!cell!sites!where!they!are!
needed.!The!ability!of!this!metal!to!undergo!redox!cycling!between!the!two!oxidative!
states! allows! it! to! participate! in! redox! reactions,! and! they! are! classified! as! redox!
active!metals.! !As!a! result! of! its! redox!potential,! copper! in! excess!of! the!needs!of!
cellular! functioning!participates! in! the!production!of!ROS!and! in!so!doing!assists! in!
the!direct!oxidation!of!lipids,!proteins!and!DNA!(Valko*et*al.,!2005).!!
!
One! of! the! proposed! mechanisms! of! actions! by! which! copper! integrated! into! a!




proteins! allows! a! link! between! the! biomolecule! being! introduced! and! the! dioxygen!
contained!in!the!protein.!In!so!doing,!it!has!the!ability!to!produce!oxidative!damage!at!
a! particular! site! (Buettner! and! Jurkiewicz,! 1996).! Copper! complexes! of! pyridineV2V
carboxamidraxones!enhanced!malarial!activity!of! the!parent!compounds.!One!such!








not! the!mechanism! of! action! by! which! the! compounds! produced! their! antimalarial!





ability! to!act!as!an!electron!withdrawing!group,! thereby!contributing! to! the!ability!of!
MA( and! MT( derivatives! to! act! as! a! proVoxidant! (Hawley* et* al.,! 1996).! The!
incorporation! of! copper,! could! possibly! contribute! to! the! redox! potential! of! the!
compound! as! it! is! a! redox! active! metal,! which! was! evident! from! the! improved!
antimalarial! activity! improved! when! copper! was! bound! to! the! base! MA( and! MT(




the!gaining!of! oxygen! (Brown!and!Lemay!Jr,! 2000).!The!methoxy! functional! group!






With!regards! to! the!MT(and!MA(derivatives,!not!only!did! the! incorporation!of!metal!
into! the!scaffold! improve!activity!but!substituents!placed!on! the!benzene!ring!could!




for! the! purpose! of! haemoglobin! proteolysis,! peptide! transport,! haematin!
polymerization! and! the! detoxification! of! oxygen! radicals! (Banerjee! and! Goldberg,!
2001).!There!is!a!pH!gradient!that!exists!between!the!external!environment!(pH!7.4)!
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and! the! acidic! food! vacuole! (pH! 5.0)! and! weakly! basic! drugs! are! proposed! to!
accumulate!easily! in!the!acidic!food!vacuole!(Figure!4.14)!(Geary*et*al.,!1986).!The!
level!of!drug!accumulation!that!is!possible!to!achieve!is!governed!by!the!redox!state!

















acidic! food! vacuole,! not! only! is! redox! state! important! but! also! the! pKa! of! the!
compounds.! Chemically,! these! two! properties! of! drugs! are! related! as! the! pH! of! a!
compound! is! determined! through! the! ability! to! behave! as! a! proton! donor.! !When!
examining! the!MA( and!MT! derivatives! the! substituents!on! the!benzene! ring!would!
have! an! effect! on! the! pKa! of! the! compound.! According! to! the! BronstedVLowry!
acid/base! theory,! a! compound! that! has! the! ability! to! act! as! a! proton! donor! is!
considered!an!acid,!and!a!compound!that!has!the!ability!to!act!as!a!proton!acceptor!
is!considered!a!base!(Brown!and!Lemay!Jr,!2000).!The!most!active!compounds!from!


















act! as! a! proton! acceptor.! In! doing! so! it! could! be! theorized! to! increase! the! pKa!
making!it!less!acidic,!and!therefore!increasing!the!accumulation!of!the!compound!into!
the!acidic! food!vacuole.!The!substitution!of!a!methyl!group!(CH3)!did!not!affect! the!






The! pKa! and! consequent! acid/base! parameters! would! also! have! on! effect! on! the!
difference! in! the! activity! of! the! two! compounds! against! the! different! strains.! As!
discussed,!studies!have!shown!a!difference!in!the!pH!of!the!food!vacuole!of!the!HB3!
chloroquineVsensitive! strain,! and! Dd2! a! chloroquineVresistant! strain,! with! the!
chloroquineVresistant! strain! having! a! slightly! more! acidic! pH.! However,! the! same!
theory!cannot!necessarily!be!applied!to!the!3D7!and!FCRV3!strain!used!in!this!study!
as! it! cannot! be! assumed! that! all! chloroquineVsensitive! and! chloroquineVresistant!
strains! share! the! same! pH! values.! As! such! further! studies! would! need! to! be!
conducted! to!determine! the!specific!pH!of! the! food!vacuole!of! these! two!strains! in!
order! to! determine! the! relation! between! pH,! different! compound! substituents! and!
drug!sensitivity.!
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one! such! example! is! the! incorporation! of! a! transition! metal! into! a! standard!
antimalarial! such! as! chloroquine! in! order! to! improve! pharmacological! properties! of!
the!drug!such!as!lipophilicity!thereby!enhancing!the!overall!activity!of!the!parent!drug.!
The! attachment! of! gold! and! ruthenium! into! a! chloroquine! scaffold! was! found! to!
enhance!the!antimalarial!activity!of!the!parent!compound!against!resistant!strains!of!
Plasmodium* falciparum! through! an! enhancement! of! lipophilicity! and! structural!
changes!to!the!parent!drug!(Navarro*et*al.,!2011).!Lipophilicity!is!an!important!is!an!
important!property! required! for!optimal!antimalarial!activity!as! the!compound!needs!
to! transverse! three! membranes! to! enter! the! parasite! and! four! to! enter! the! food!






Another! strategy! would! be! to! incorporate! a! metal! into! the! scaffold! of! a! known!




compound,! ferroquine! is!another!example!of!an!organometal,!where! ferrocene!has!
been! integrated! into! a! chloroquine! scaffold.! Ferroquine! displayed! activity! against!
both!chloroquineVsensitive!as!well!as!chloroquineVresistant!P.!falciparum!and!P.!vivax!
strains.!The!activity!of! ferroquine!provides!a!unique!dual!mechanism!of!action.!The!









The! next! step! in! the! use! of! metals! in! malaria! treatment! would! be! to! explore! the!
synthesis!of!metalVbased!parent!drugs!based!on!new!targets.!Although!this!may!be!a!
feasible!alternative,!careful!study!would!need!to!be!completed!to!ensure!there!is!no!
disruption! of! the! metal! homeostasis! as! a! result! of! metal! being! released! form! the!
metal!chelatef!as!this!could!potentiate!the!already!challenged!metal!homeostasis! in!
the!infected!host!(Seyrek*et*al.,!2005).!As!such,!although!the!current!configuration!of!
metal!binding! to! the!MA(and!MT!derivatives!did!not!affect! the!RBC! integrity!of! the!






When! comparing! the! antiVoxidant! activity! of! the!MT! and!MA! derivatives! using! the!
DPPH!assay!(Appendix!C:!Table!C.4)!it!was!noted!that!only!the!compounds!bound!to!
nickel! and! cobalt! displayed! potent! free! radical! scavenging! activity,! to! a! greater!
degree!than!Trolox™.!It!is!significant!to!note!that!both!cobalt!and!nickel!have!proven!




in! the! ability! of! cobalt! and! nickel! to! produce! peroxides! revealed! that! thiol! (VSH)!
chelators! such! as! cysteine! activated! both! nickel! and! cobalt’s! ability! to! produce!
peroxide!radicals!(Shi*et*al.,!1993).!When!examining!the!base!structures!of! the!MA!
group!(Figure!4.15),! it!could!be!proposed!that!the!presence!of!the!thiol!group!could!
have!played!a! role! in! its!ability! to!behave!as!an!antiVoxidant.!Based!on! the! results!
obtained! it! is! evident! that! the! methoxy! substituent! at! the! para* position! in! the!
compounds!bound!to!nickel!and!cobalt!slightly!improved!the!free!radical!scavenging!
activity!when!compared!to!the!ortho*position!of!the!substituent.!For!example,!the!para!
substituted! Ni4MeO2MA! (IC50! value:! 9.63! ±! 0.69( µM)! compared! to! the! ortho*
substituted!Ni6MeO2MA!(IC50!value:!11.4!±!1.21(µM)!(Appendix!C:!Table!C.4).!When!
comparing! the! MT! and! MA( groups! it! is! important! to! note! that! although!













Nickel! is! found! in! several! oxidative! states,! and! although! its! therapeutic! use! is!
relatively! unexplored! it! most! notably! plays! a! significant! role! in! plant! systems!
(Zamponi*et*al.,!1996).!Nickel!has!been!proposed!to!initiate!lipid!peroxidation!through!
the!production!of!hydroxyl!radicals!due!to!the!interaction!with!hydrogen!peroxide!and!
the! superoxide! radical! (Chen* et* al.,! 2002).!Cobalt! is! considered!an!essential! trace!
element,!as!the!body!is!unable!to!synthesize!it!and!as!such!it!must!be!obtained!from!
external! sources! (Roth* et* al.,! 1996).! The! most! significant! use! of! cobalt! is! as! an!
integral! part! of! vitamin! B12.! Cobalt! has! proven! to! induce! a! carcinogenic! effect!
through! the! production! of! freeVradicals! in! reaction! to! hydrogen! peroxide.!
(Beyersmann! and!Hartwig,! 1992).! Although! both! nickel! and! cobalt! have! proven! to!
display!a!proVoxidant!effect,!when!bound! to! the!MA( derivatives! it! has! the!opposite!




quercetin,! it!was! revealed! that! the! integration!of! cobalt! into! the!complex!enhanced!
the! antiVoxidant! activity! of! the! parent! compounds,! through! a! decrease! in! oxidation!






















The! use! of! the!DPPH! free! radical! scavenging! assay! to! determine! the! antiVoxidant!
behaviour!of! the!novel! compound!allows!a!very!conservative! indication!of! the!antiV
oxidant! activity.! This! assay! is! based! on! the! ability! of! the! compound! to! bind! to! the!
unpaired!electron! found!on! the!DPPH!radical,!as!such!determines! the!ability!of! the!
compound! to! act! as! a! proton! donor.! In! the! case! of!Ni4MeO2MA,( Co4MeO2MA,(











the! antiVoxidant! activity! using! the! lipid! peroxidation! inhibition! assay! revealed! the!
compounds! bound! to! copper! produced! an! inhibitory! effect! on! lipid! peroxidation,!
thereby!exhibiting!antiVoxidant!behaviour!(Appendix!C:!Table!C.5)!(Figure!4.9).!!The!
integration!of!copper!into!the!MT!and!MA!derivatives!had!a!very!potent!effect!on!the!
ability! of! the! compound! to! inhibit! lipid! peroxidation,!where! the!%! lipid! peroxidation!
inhibition! activity! at! 50! μM! of! the! base! compound! 2MT! increased! from! 2.69%! to!
78.08%! for!Cu2MT! when! copper! was! integrated! into! the! compound! (Appendix! C:!
Table!C.5)!
!
When! comparing! the! lipid! peroxidation! inhibition! activity! between! the!MT! and!MA(
groups!the!activity!was!similar!for!most!of!the!compounds!with!a!few!exceptions.!The!




the! compound,! the! MT( derivative,! CupMeO2MT( (IC50! value:! 5.67! ±! 0.41! μM)(







The! integration! of! halides! such! as! Br! and! Cl! into! the! copper! bound! compounds!
maintained!the!inhibition!activity,!and!in!the!case!of!the!Cu2MA,!the!inhibitory!activity!
was!slightly! improved!with! the!substitution!of!Cl!at! the!para*position.! !Studies!have!
shown! that! the! substitution! of! halides! such! as! Br! and! Cl! with! copper! showed! a!
slightly! improved! activity! of! the! complex! when! compared! to! the! unbound! parent!
ligands.!This!was!as!a!result!of!the!anion!or!negative!charge!on!the!halide!affecting!






Copper! is! found! in!different! redox!states,!as!such! it!has! the!ability! to!participate! in!
redox! reactions! (Seyrek* et* al.,! 2005).! With! regards! to! antimalarial! activity,! it! is!
proposed! to!act! through! the!generation!of!ROS!within! the!parasite! (Gokhale*et*al.,!
2006)f! although! if! this! is! so,! its! cationic! nature! or! positive! redox! state! allows! it! to!
behave! as! a! free! radical! scavenger! with! antiVoxidant! activity! (Wu* et* al.,! 2011).!
Several!studies!conducted!on!various!compounds!to!determine!the!effect!integrating!
copper! into! a! compound! would! have! on! antiVoxidant! activity.! One! such! study!
compared! the! antiVoxidant! activity! of! cobalt! and! copper! complexed! to! a!
benzimidazole! ligand.! The! study! revealed! that! the! compound! containing! copper!
displayed! more! effective! hydroxyl! radical! scavenging! activity! than! the! compound!
complexed! to! cobalt,! as! well! as! ascorbic! acid! (Wu* et* al.,! 2011).! A!more! complex!
study! investigated! the! use! of!mixed! ligand! copper! complexes! to!mimic! superoxide!




2015).! The! use! of! copper! bound! to! acyclic! ligands! revealed!moderate! antiVoxidant!
activity!in!a!concentration!dependant!manner!(Rathi!and!Singh,!2015),!which!was!the!




















The!proposed! theory! in!which! the! copper!bound!MA!and!MT!derivatives!produced!




displayed! the! ability! to! act! as! a! proVoxidant,! as! well! as! an! antiVoxidant.! Although!
CupMeO2MT! was! unable! to! scavenge! DPPH! free! radicals! as! a! measure! of! antiV
oxidant! activity! (Appendix! C:! Table! C.4).! The! ability! of! copper! to! act! as! an! antiV
oxidant! in* vitro! is!greatly! influenced!by! its!molecular! structure.!The! flexibility!of! the!
Cu(II)! arrangement! determines! the! possibility! of! electron! transfer! which! results! in!
reduction!to!Cu(I).!Limited!steric!hindrance!between!copper!and!the!oxygen!radical!in*
vitro* allows! it! to! exchange! molecules! rapidly,! and! the! stabilizing! effect! of! the! πV
electrons! on! the! complex! formed! between! copper! and! the! oxygen! radical! all!
contribute! to! its! antiVoxidant! activity! (Mehta* et* al.,! 2015).! Therefore! the! molecular!
structure!of!the!copper!bound!to!the!MT(and!MA(derivatives!would!have!an!effect!on!







concentration.! At! high! concentrations! it! acts! as! a! proVoxidant,! and! at! low!
concentrations! it! tends!to!act!as!an!antiVoxidant!(Buettner!and!Jurkiewicz,!1996).! In!
this!study!screening!was!conducted!at!the!same!concentration!for!all!the!assays,!as!




measuring! the! rate! at! which! transition!metals!would! initiate! the! Fenton! reaction! in!
biological!systems!would!be!dependant!on!the!type!of!buffer!chosen!to!complete!the!
reaction! in,!as!buffers!could!affect! the!metal!binding!capabilities! (HEPES!>!TRIS!>!
phosphate!buffer).!It!has!been!reported!that!changes!in!pH!play!a!role!in!the!ability!of!
the! transition! metals! to! participate! in! FentonVlike! reactions! to! produce! oxidizing!
species.! At! increased! pH! levels,! iron! was! inactivated,! and! unable! to! produce!
oxidizing!speciesf!whilst!copper!was!able!to!still!produce!an!effect.!Cobalt!displayed!
an! increase!in!activity!as!the!pH!increased,!but!at!very!high!pH!levels!(>8.9)! it!was!
deactivated! (Strlič* et* al.,! 2003).! Nickel’s! activity! increased!with! an! increase! in! pH,!
specifically!at!7.8.!As!such!there!was!a!general!increase!in!the!rate!of!production!of!
oxidizing!species!as!the!pH!was!increased.!At!a!neutral!pH!the!decreasing!rates!of!
production!of! oxidizing! species!was!as! follows:!Cu(II)! >!Co(II)! >!Ni(II)! (Strlič* et* al.,!
2003).! Therefore! one! could! propose! that! pH! could! play! a! role! in! the!MA( or!MT!
compounds!ability!to!display!proVoxidant!or!antiVoxidant!behaviour.!!
!
Oxidative! damage! to! lipids! result! in! changes! to! cellular!membranes!which! have! a!
direct! result!on!cellular! function!contributing! to!various!pathological!conditions!such!
as! cancer,! heart! disease! and! diabetes! (Kohen! and! Nyska,! 2002).! The! degree! of!
efficacy!of!antiVoxidants! to!protect!against!oxidative!damage! to! lipids!would! rely!on!
the! compounds! lipophilicity.! The! compounds! ability! to! be! incorporated! into! a! lipid!
bilayer!directly!effects!the!even!distribution!of!the!compound!into!a!lipid!bilayer.!The!
more!evenly!distributed!it!is!the!more!accessible!the!protons!are!to!interact!with!free!
radicals! found!on! the!surface! (Zhang*et*al.,!2006).!The!copper!bound!MA(and!MT!
derivatives!have!displayed! lipid!peroxidation!activity!comparable! to! that!of!Trolox™!
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The! antimalarial! activity! of! the!MT! and!MA( derivatives! were! directed! against! the!
intraVerythrocytic!parasite!rather!than!affecting!the!integrity!of!the!host!red!blood!cell!
as! the!compounds!displayed!negligible!haemolytic!activity! (Appendix!C:!Table!C.1f!
Table! C.2).! When! considering! the! safety! index! calculated! for! the! compounds! by!
comparing! the!antimalarial! effect! to! the! cytotoxic! effect! on!human!kidney!epithelial!
cells,! it! was! noted! that! although! CupMeO2MT! and! Cu4MeO2MA( displayed!






Of! the! compounds! tested! for! antimalarial! activity,! most! of! the! compounds! were!
relatively!safe!with!less!than!50%!cytotoxic!to!the!nonVcancerous!kidney!cells,!and!no!
effect! on! the! integrity! of! the!RBCs! by! all! the! compounds! (Appendix!C:! Table!C.1f!
Table! C.2).! Although! these! results! demonstrate! a! positive! result! in! terms! of! initial!
safety! studies,! it! has! been! shown! that! antiVoxidant! compounds! have! the! ability! to!
interfere! with! cell! proliferation! results! when! using! the! MTTVbased! cellular! viability!
assay!(Bruggisser*et*al.,!2002).!Therefore,!further!studies!using!other!cellular!viability!
methodologies! (such! as! tritiated! thymidine! incorporation)! should! be! conducted! in!





!When! considering! the! cytotoxic! properties! of! the! compounds! on! the! leukemic! cell!
line! compared! to! the! nonVcancerous! human! kidney! epithelium! cell! line,! the!
compounds!were! observed! to! be!more! selective! to! the! human! kidney! cell! line,! as!
indicated! by! the! small! SInc!values! (Table! 4.4)! (Figure! 4.6).! However! there!was! no!




ligand!2MT! (105%)!and! the!copper!bound!Cu2MT( (4.65%)!at!50!μM,! it!was!noted!
that!the!introduction!of!copper!played!a!substantial!role!in!the!antiVproliferative!activity!
of! the! compounds! (Appendix! C:! Table! C.3).!CupMeO2MT( (Figure! 4.6)( displayed!
greater! cytotoxic! activity! on! the! leukemic! cell! line! when! compared! to! the! nonV
cancerous! kidney!epithelium.!This! is! in! contrast! to!CupMe2MT( (Figure!4.6),!which!
displayed! greater! cytotoxic! activity! on! the! nonVcancerous! kidney! epithelium!
compared! to! the! leukemic! cell! line.! However! in! contrast! to! camptothecin! the!
compounds! inhibitory! activity! was! negligible,! and! further! studies! would! need! to!
confirm!on!additional!cell!lines!and!an!additional!cellular!viability!assay.!Studies!have!
shown! that! compounds! bound! to! nickel! and! cobalt! have! the! ability! to! produce! a!
carcinogenic!effect!(Valko*et*al.,!2006),!but!the!binding!of!Co!and!Ni!to!the!MA!and!
MT! derivatives! did! not! effect! its! ability! to! do! so.! As! evident! from! the! K562! cell!





activity!of! the!copper!bound!MT! and!MA! derivatives!on! the! two!different! cell! lines.!
The!use!of!metals! in!cancer! therapy! is!not!a!new!concept,!where!one!of! the!most!
commonly!used!antiVproliferative! therapies! is!a!platinum!based!compound,!cisplatin!
(Kostova,! 2006).! ! Apart! from! this,! copper! homeostasis! plays! an! integral! role! in!
carcinogenesis!with!studies!proving! that!cancer!cells!proliferate! into! tumours!easier!
under! highVcopper! environments.!As! such!a! drug!with! a! copperVlowering! capability!
has! been! proposed! for! antiVproliferative! activity! (Valko* et* al.,! 2006).! The! use! of!
copper!complexed!to!not!only!novel!compounds,!but!known!antiVproliferative!agents!
have!proven!successful.!Studies!have!proven!the!use!of!organic!copper!complexes!
inhibiting! proteasome! activity! in* vivo! and! in* vitro,* induce! apoptosis! resulting! in!
producing!an!antiVproliferative!effect!(Daniel*et*al.,!2004).!Studies!conducted!on!the!
use!of!copper!complexed!to!doxorubicin!a!known!antiVproliferative!agent!has!proven!


























of!copper! into! the!MT!and!MA!derivatives!showed!a!clear! improvement!on!antiV
proliferative!activity.!
•! Further! studies! would! need! to! be! conducted! in! order! to! establish! whether! the!
copper! bound! compounds! produced! their! antimalarial! effect! through! the! use! of!
the!production!of!ROS,!as!well!as!to!determine!their!pKa!values!and!the!effect!the!
antiVoxidant! compounds! would! have! on! cell! proliferation! using! an! assay! other!
than!the!MTTVbased!cellular!viability!assay.!!













although! vastly! different! in! their! chemical! aspects,! both! were! composed! of! two!
entities! to! compliment! each! other’s! individual! activity.! In! the! case! of! the!
aminoquinoline! derivatives,! it! was! the! use! of! two! very! different! compounds!
incorporated! through! the!use!of!crystal!and!salt! formation.!These!compounds!were!




The! use! of! crystal! and! salt! formation! proved! advantageous! in! certain! aspects! as!
various!components!of!the!parent!compound!were!retained,!such!as!the!antiVoxidant!
activity!of!gallic!acid!in!compound!III!and!8Vhydroxyquinoline!compound!V.!While!the!
use! of! multicomponent! systems! and! coVcrystals! provides! a! novel! approach! to! the!
method!in!which!drugs!may!be!delivered.!The!challenge!with!regards!to!its!use!is!the!




produce! a! proposed! proVoxidant! effect! in! compound! I! in! a! salt! form,! and! a! potent!







ligands! proved! successful! in! improving! antimalarial! activity,! as! well! as! the! antiV
oxidant!activity!through!the!inhibition!of!lipid!peroxidation.!The!proposed!mechanism!
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of!action! is! through!a!proVoxidant!effect.! In! this! respect! the! incorporation!of!copper!
into! the! base! ligands! proved! to! display! a! proVoxidant,! as! well! as! an! antiVoxidant!
effect.! The! various! substituents! at! the!ortho! and!para*positions! proved! to! have!an!
influence!on! the!activity!of! the!compounds.!The!binding!of! cobalt!and!nickel! to! the!
MA!derivatives!enhanced!the!metals’!ability!to!effectively!scavenge!free!radicals.!The!
use! of! incorporating! metals! into! compounds! as! a! means! of! enhancing! activity,! or!
improving! the! physicochemical! properties! of! a! compound,! could! prove! beneficial.!
Although!this! is! true!the!disruption!of!metal!homeostasis! is!always!a!possibility!and!
care! should! be! taken! when! introducing! metals! into! the! body.! CupMeO2MT( and(
Cu4MeO2MA( both! displayed! antimalarial! activity! without! having! an! effect! on! red!
blood!cell!membrane!integrity,!as!well!as!a!safety!index!>10.!CupMeO2MT!displayed!
potent! inhibition! of! lipid! peroxidation! and! further! investigation! would! need! to! be!
conducted!on!its!ability!to!act!possibly!as!a!proVoxidant,!as!well!as!antiVoxidant.!!
!
While! the!use!of!a!proVoxidant!as!an!antimalarial! could!prove!effective! in! inhibiting!
growth! of! the!malaria! parasite! the! challenge!with! regards! to! its! use! is! the! lack! of!
specificity!in!the!manner!in!which!these!compounds!produce!an!effect,!with!the!risk!of!
causing! oxidative! damage! to! biological! targets.! This! study! has! investigated! the!
possible! antimalarial! activity! of! novel! compounds! and! with! current! research! being!
aimed!at! the!next!generation!of!hybrid!antimalarial! compounds!being! focused!as!a!
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Salts) IFIII)and)cocrystal) ) IV)were)prepared)by)crystallization)of)solution)of) )1:1)mole)
ratio) ) of! the) corresponding!aminoquinoline)and) respective)hydroxyaromatic) acid.) In!
each)case,)aminoquinoline)and)hydroxyaromatic)acid)was)dissolved)in)methanol)and)


































Compounds) VFVI) were) prepared) by) reported) procedure) [7].) Compound) VII) was)
prepared) by) published) procedure) [5].) Synthesis) of) ethylZ4Z(2ZoxoZ2Z(quinolinZ8Z
ylamino)ethoxy)benzoate)(VIII):)To)a)solution)of)8Zaminoquinoline)(0.72)g,)5)mmol))in)
dry) dichloromethane) (20)ml),) triethylamine) (0.71)ml,) 5)mmol)) was) added.) Solution)
was)stirred)at)0ºC) for)15)mins,) followed)by)which)bromoacetyl)bromide) (0.52)ml,)6)
mmol))was)added.)Reaction)mixture)was) then)stirred)overnight)and) filtered.)Filtrate)
was)washed)with)water)(10)ml),)dried)over)anhydrous)sodium)sulphate)and)then)the)
solvent) was) removed) under) reduced) pressure.) Product) was) obtained) as) a) brown)
solid)that)was)purified)by)recrystallisation)from)dichloromethane.)Amide)obtained)from)
above) reaction) (0.53) g,) 2) mmol),) ethyl) 4Zhydroxybenzoate) (1.66) g,) 10) mmol)) and)















2H),) 1.37) (t,! J) =) 7.2) Hz,) ) 3H).) ) ESI) mass:) 351.0266.) Calcd.) Mass) for) [M) +) 1]:)
C20H19N2O4,)351.1345.)
































































































































































2MT( 4.06)±)2.88) 56.25)±)9.56) n.d)
Cu2MT) 15.2)±)2.47) 6.35)±)20.67) 15.35)±)4.22)
Co2MT) 0.35)±)0.09) 70.41)±)16.35) n.d)
pCl2MT) 3.08)±)2.32) 62.09)±)12.09) n.d)
oCl2MT) 3.97)±)2.76) 54.18)±)6.04) n.d)
CupCl2MT) 16.73)±)0.71) 52.0)±)7.08) n.d)
CuoCl2MT) 16.65)±)0.78) 57.2)±)11.13) n.d)
CopCl2MT) 1.24)±)0.35) 56.28)±)7.07) n.d)
pBr2MT) 1.9)±)1.39) 57.26)±)10.73) n.d)
oBr2MT) 0.1)±)0.01) 69.53)±)15.61) n.d)
CupBr2MT) n.d) 56.15)±)7.38) n.d)
CuoBr2MT) 17.19)±)1.25) 53.14)±)6.17) n.d)
CopBr2MT) 1.27)±)0.76) 61.77)±)17.5) n.d)
CooBr2MT( 0.02(±)0.95( 78.7)±)20.5) n.d)
oNO2MT( 2.25)±)1.39( 54.05)±)5.58) n.d)
CupNO22MT( 22.59)±)2.02) 54.29)±)5.49) n.d)
CopNO22MT( 6.49)±)1.44) 64.85)±)5.75) n.d)
pMe2MT( 1.22)±)1.54) 56.02)±)11.84) n.d)
oMe2MT( 3.54)±)2.85) 57.53)±)13.29) n.d)
CopMe2MT( 0.36)±)0.13) 66.15)±)9.45) n.d)
CooMe2MT( 0.98)±)0.24) 52.9)±)8.02) n.d)
CupMe2MT( 14.47)±)0.91) 20.24)±)8.8) 11.23(±(2.86(
CuoMe2MT( 21.7)±)0.97) 5.81)±)1.28) 20.48)±)2.84)
pMeO2MT( 2.98)±)1.61) 60.1)±)11.13) n.d)
oMeO2MT( 2.37)±)1.74) 65.21)±)17.61) n.d)
CopMeO2MT( n.d) 62.5)±)4.88) n.d)
CooMeO2MT( 1.98)±)1.48) 63.46)±)3.45) n.d)
CupMeO2MT) 0.1)±)0.01) 4.51)±)1.0) 29.03)±)6.89)
CuoMeO2MT( 3.27)±)0.55) 16.33)±)9.34) 41.85)±)8.56)
NipMeO2MT( 1.98)±)0.53) 59.69)±)5.23) n.d)
NioMeO2MT( 1.06)±)0.69) 59.98)±)9.87) n.d)
Chloroquine) 2.09(±(0.59) n.d) n.d)
Quinine) 8.22(±(2.17) n.d) n.d)









































2MA) 0.86)±)2.31) 57.13)±)6.06) n.d)
Cu2MA) 13.04)±)16.86) 25.22)±)11.91) 71.92)±)7.63)
Co2MA) 5.47)±)4.22) 79.7)±)15.95) n.d)
4Cl2MA) 10.62)±)13.3) 66.37)±)7.54) n.d)
6Cl2MA) 9.17)±)12.38) 55.63±)5.15) n.d)
Cu4Cl2MA) 22.75(±(1.08( 50.37±)5.52) n.d)
Cu6Cl2MA) 15.46)±)23.73) 50.4)±)6.72) n.d)
Co4Cl2MA) 1.66)±)0.77) 54.28)±)4.51) n.d)
4Br2MA) 5.95)±)4.97) 52.16)±)2.12) n.d)
Cu4Br2MA) 17.42)±)25) 52.34)±)2.98) n.d)
Cu6Br2MA) 15.04)±)23.57) 53.02)±)1.62) n.d)
4Me2MA) 1.69)±)1.83) 57.98)±)14.04) n.d)
6Me2MA) 1.24)±)2.15) 55.97)±)7.02) n.d)
Co4Me2MA) 2.63)±)0.62) 72.89)±)16.83) n.d)
Cu4Me2MA( 21.94)±)2.80( 52.55)±)3.52( n.d(
Cu6Me2MA) 8.83)±)4.17) 21.51)±)5.23) 66.99)±)3.74)
4MeO2MA) 2.76)±)2.79) 66.3)±)11.2) n.d)
6MeO2MA) 2.73)±)2.87) 64.06)±)10.42) n.d)
Co4MeO2MA) 6.37)±)1.6) 58.84)±)9.46) n.d)
Co6MeO2MA) n.d) 68.89)2.73) n.d)
Cu4MeO2MA) 3.23)±)1.19) 9.41)±)8.33) 46.97(±(10.32)
Cu6MeO2MA) 7.43(±)2.11) 27.48)±)11.0) 75.78)±)2.8)
Ni4MeO2MA) 4.66)±)1.35) 51.95)±)13.05) n.d)
Ni6MeO2MA) 2.22)±)0.46) 65.74)±)7.7) n.d)
Chloroquine( 2.09(±(0.59) n.d( n.d(
Quinine( 8.22(±(2.17) n.d( n.d(






















2MT( 105)±)5.88) n.d) 2MA( 103.83)±)12.64( n.d(
Cu2MT) 4.65)±)1.98) 33.5)±)6.1) Cu2MA( 9.5))±)2.7) 24.07))±)5.56)
Co2MT) 91.88)±)13.66) n.d) Co2MA( 80.8)±)21.7) n.d)
pCl2MT) 113.8)±)10.33) n.d) 4Cl2MA( 87.52))±)6.4) n.d)
oCl2MT) 139.03))±)34.33) n.d) 6Cl2MA( 101)±)6.7) n.d)
CupCl2MT) 61.24)±)2.79) n.d) Cu4Cl2MA( 88.6))±)8.2) n.d)
CuoCl2MT) 63.44)±)13.18) n.d) Cu6Cl2MA( 73.59))±)7.5) n.d)
CopCl2MT) 72.83))±)18.82) n.d) Co4Cl2MA( 82.74)±)21.73) n.d)
pBr2MT) 113.44))±)15.26) n.d) 4Br2MA( 92.87))±)15.34) n.d)
oBr2MT) 132.32))±)28.2) n.d) ( ) )
CupBr2MT) 67.45)±)9.55) n.d) Cu4Br2MA( 96.46))±)3.29) n.d)
CuoBr2MT) 70.41)±)17.39) n.d) Cu6Br2MA( 65.44))±)8.95) n.d)
CopBr2MT) 68.38))±)16.83) n.d) ( ) )
CooBr2MT( 79.86)±)16.43) n.d) ( ) )
oNO2MT( 64.74)±)6.37) n.d) ( ) )
CupNO22MT( 61.32)±)6.3) n.d) ( ) )
CopNO22MT( 75.5)±)12.83) n.d) ( ) )
pMe2MT( 104.86)±)6.5) n.d) 4Me2MA( 103.07))±)7.25) n.d)
oMe2MT( 112.58)±)4.32) n.d) 6Me2MA( 93.7))±)18.8) n.d)
CopMe2MT( 72.53)±)20.14) n.d) Co4Me2MA) 64.65)±)10.96) n.d)
CooMe2MT( 83.54)±)12.97) n.d) ( ) )
CupMe2MT( 4.2)±)3.02) 24.83)±)1.27) Cu4Me2MA( 75.4))±)8.1) n.d)
CuoMe2MT( 3.73)±)9.23) 22.9)±)0.4) Cu6Me2MA) 65.94))±)6.92) n.d)
pMeO2MT( 110.01))±)12.22) n.d) 4MeO2MA) 86.23))±)6.8) n.d)
oMeO2MT( 118.21))±)2.31) n.d) 6MeO2MA) 110.28))±)8.59) n.d)
CopMeO2MT( 76.23)±)17.43) n.d) Co4MeO2MA) 74.12)±)8.36) n.d)
CooMeO2MT( 74.78)±)14.79) n.d) Co6MeO2MA) 65.84)±)11.08) n.d)
CupMeO2MT( 0.1(±(0.01( 12.25((±(1.97( Cu4MeO2MA) 0.1)±)0.01) 25.06)±)3.65)
CuoMeO2MT) 11.58)±)1.82) 14.66)±)2.32) Cu6MeO2MA) 59.05)±)9.11) n.d)
NipMeO2MT( 66.79)±)10.47) n.d) Ni4MeO2MA) 77.89)±)19.38) n.d)
NioMeO2MT( 64.59)±)5.65) n.d) Ni6MeO2MA) 75.64)±)19.05) n.d)































2MT) 0.10)±)0.01) n.d) 2MA) 0.10)±)0.01) n.d)
Cu2MT) 4.51)±)1.21) n.d) Cu2MA) 6.07)±)1.12) n.d)
Co2MT( 0.10)±)0.01) n.d( Co2MA( 0.10)±)0.01( n.d(
pCl2MT) 0.10)±)0.01) n.d) 4Cl2MA) 0.10)±)0.01) n.d)
oCl2MT) 0.10)±)0.01) n.d( 6Cl2MA) 0.10)±)0.01) n.d(
CupCl2MT( )2.86)±)0.41) n.d( Cu4Cl2MA( 0.10)±)0.01( n.d(
CuoCl2MT) 5.12)±)0.48) n.d) Cu6Cl2MA) 6.59)±)0.37) n.d)
CopCl2MT) 0.10)±)0.01) n.d) Co4Cl2MA) 0.10)±)0.01) n.d)
pBr2MT) 0.10)±)0.01) n.d) 4Br2MA) 0.10)±)0.01) n.d)
CupBr2MT) n.d) n.d) Cu4Br2MA) 8.01)±)1.37) n.d)
CuoBr2MT) 4.36)±)0.87) n.d) Cu6Br2MA) 0.42)±)0.36) n.d)
CopBr2MT) 0.10)±)0.01) n.d) ) ) )
CooBr2MT( 0.10)±)0.01( n.d( ( ( (
oNO2MT( 0.10)±)0.01( n.d( ( ( (
CupNO22MT( 2.34)±)0.75( n.d( ( ( (
CopNO22MT( 0.10)±)0.01( n.d( ( ( (
pMe2MT( 0.10)±)0.01( n.d( 4Me2MA( 0.10)±)0.01( n.d(
oMe2MT( 0.10)±)0.01( n.d( 6Me2MA( 0.10)±)0.01( n.d(
CopMe2MT) 0.10)±)0.01( n.d( Co4Me2MA( 0.10)±)0.01( n.d(
CooMe2MT) 0.10)±)0.01( n.d( ( ( (
CupMe2MT) 6.31)±)0.66( n.d( Cu4Me2MA) 11.56)±)2.83( n.d(
CuoMe2MT) 5.56)±)1.24( n.d( Cu6Me2MA( 5.00)±)0.95( n.d(
pMeO2MT) 13.34)±)2.18( n.d( 4MeO2MA) 37.56)±)5.49) n.d)
oMeO2MT) 0.10)±)0.01( n.d( 6MeO2MA( 52.54)±)3.42)) n.d(
CopMeO2MT) n.d( n.d( Co4MeO2MA( 62.65)±)3.20) 9.86))±)1.53(
CooMeO2MT) 1.77)±)0.58)( n.d( Co6MeO2MA( 62.00)±)2.35( 13.3)±)1.15(
CupMeO2MT( 11.82)±)0.75( n.d( Cu4MeO2MA) 11.77)±)1.81( (
CuoMeO2MT) 5.92)±)1.14( n.d( Cu6MeO2MA( 2.65)±)0.78( (
NipMeO2MT) 32.25)±)4.47( n.d( Ni4MeO2MA( 68.14)±)1.16( (((((9.63(±(0.69(
NioMeO2MT) 3.06)±)1.53( n.d( Ni6MeO2MA( 71.06)±)0.78( 11.4)±)1.21(



































2MT) 2.69)±)0.92) n.d) 2MA) 0.10)±)0.01) n.d)
Cu2MT) 78.08)±)1.21) 6.1)±)2.0) Cu2MA) 83.44)±)11.23) 7.51)±)1.95)
Co2MT( 0.10)±)0.01) n.d( Co2MA( 2.82)±7.49( n.d(
pCl2MT) 0.10)±)0.01) n.d) 4Cl2MA) 0.10)±)0.01) n.d)
oCl2MT) 4.64)±)1.82) n.d) 6Cl2MA) 0.10)±)0.01) n.d(
CupCl2MT( 75.81)±)11.45) 8.33)±)2.09( Cu4Cl2MA( 72.25)±)8.09) 6.57(±(1.71(
CuoCl2MT) 73.69)±)22.35) 19.24)±)1.26) Cu6Cl2MA( 81.63)±)8.0( 17.2)±)2.96(
CopCl2MT) 0.10)±)0.01) n.d) Co4Cl2MA) 0.10)±)0.01) n.d)
pBr2MT) 0.10)±)0.01) n.d) 4Br2MA) 5.39)±)2.52) n.d)
CupBr2MT) n.d) n.d) Cu4Br2MA) 8.01)±)1.37) n.d)
CuoBr2MT) 78.44)±)15.55) 9.26)±)1.32) Cu6Br2MA) 81.48)±)3.47) 17.91)±)4.21)
CopBr2MT) 0.10)±)0.01) n.d) ) ) )
CooBr2MT( 0.10)±)0.01( n.d) ( ( (
oNO2MT( 0.10)±)0.01( n.d( ( ( (
CupNO22MT( 43.87)±)15.04) n.d( ( ( (
CopNO22MT( 0.10)±)0.01( n.d( ( ( (
pMe2MT( 1.85)±)0.16( n.d( 4Me2MA( 6.85)±)2.56( n.d(
oMe2MT( 0.10)±)0.01( n.d( 6Me2MA( 24.43)±)11.33( n.d(
CopMe2MT) 0.10)±)0.01( n.d( Co4Me2MA( 0.10)±)0.01( n.d(
CooMe2MT) 0.10)±)0.01( n.d( ( ( (
CupMe2MT) 76.03)±)18.18( 12.99)±)3.52) Cu4Me2MA) 71.59)±)7.68( 13.0)±)2.42(
CuoMe2MT) 73.47)±)13.29( 13.42)±)3.06( Cu6Me2MA( 75.68)±)14.32( 11.41)±)1.77(
pMeO2MT) 27.47)±)8.66( n.d( 4MeO2MA) 68.84)±)6.95) 27.77)±)7.19)
oMeO2MT) 6.16)±)2.77( n.d( 6MeO2MA( 79.94)±)4.92) 15.29)±)1.14(
CopMeO2MT) n.d( n.d( Co4MeO2MA( n.d( n.d(
CooMeO2MT( 4.06)±)8.79( n.d( Co6MeO2MA( n.d( n.d(
CupMeO2MT( 73.92)±)19.77) 5.67(±(0.41( Cu4MeO2MA) 79.82)±)10.6( 18.1)±)1.51(
CuoMeO2MT) 79.9)±)18.13( 20.42)±)3.73( Cu6MeO2MA( 87.7)±)4.35( 27.25)±)2.99(
NipMeO2MT) 59.76)±)12.48( n.d( Ni4MeO2MA( n.d( n.d(
NioMeO2MT) 9.1)±)7.0( n.d( Ni6MeO2MA( n.d( n.d(
Trolox™) 70.35(±(2.84( 5.53(±(0.54( ( ( (
